UICC Annual Report 2025

2025 Annual Report

Message from the President

In a year marked by uncertainty and uneven progress in global health, it is remarkable what we have managed to achieve as a community through sustained commitment, collaboration and a shared sense of purpose.

The determination shown by UICC’s members, who stand at the heart of our organisation’s mission, was especially important this year. Their efforts, together with the engagement of partners and our wider network, helped maintain cancer control as a priority. This included continued focus on practical steps to help countries prevent, detect, and treat cancer, and to support people affected by the disease.

One of the clearest signals of this collective strength was World Cancer Day. The first year of the United by Unique campaign resonated across our membership and beyond, with strong reach across social and traditional media. It was heartwarming to see so many taking part in the Upside Down Challenge – sharing a photo or video of themselves upside down, and a personal story about how cancer has affected them – a reminder of how many lives around the world are affected by cancer.

We also strengthened support for national leadership. In May, UICC hosted the inaugural Cancer Planners Forum, in partnership with the World Health Organization (WHO), International Agency for Research on Cancer (IARC), and International Atomic Energy Agency (IAEA), bringing together national cancer control planners from 40 countries. Even amid development aid cuts and political uncertainty, we are seeing innovative, evidence-based, and practical approaches emerging across regions, rooted in local realities. We look forward to welcoming participants again for the second edition of the Cancer Planners Forum on 13–15 May 2026 in Geneva.

In November, the World Cancer Leaders’ Summit in Melbourne offered another moment of connection and shared purpose. Meeting so many of our members, partners, and other important actors in global health, I was reminded as always of the remarkable strength and diversity of our community.

The Summit also marked the launch of the World Cancer Declaration 2025–2035, endorsed by leaders during the meeting and now supported by organisations across the cancer community. This is intended to act as a shared framework that members and partners can use to reinforce accountability and increase investment in quality cancer services.

UICC continued to grow its membership through 2025, bringing together organisations across the globe working in prevention, care, research, and advocacy, including groups led by, and working alongside, people with lived experience of cancer.

On the global policy front, UICC welcomed the adoption of the UN Political Declaration on Noncommunicable Diseases (NCDs) and Mental Health. The Declaration includes commitments relevant to cancer control, and emphasises how progress will depend on follow-through at country level, backed by financing, strong health systems, and action that reaches communities who are too often left behind.

Thank you for your continued trust and engagement. It is a privilege to serve as UICC President, and I look forward to building on this foundation with all of you in the year ahead.

Ulrika Årehed Kågström President,

Union for International Cancer Control

Message from the CEO

For many health organisations in Geneva, 2025 was an extremely difficult year. As the ramifications of the various political decisions unravelled, many international organisations cut back, releasing staff and halting programmes and initiatives affecting the lives of millions around the world. The full implications on the cancer community will surface in the coming years, but we can expect and demand increased local ownership given the reduced role for international organisations, which have traditionally funded the health systems and responses to the disease burden of developing countries.

UICC’s funding model has proved to be resilient given the wider context and we concluded the year with a balanced budget, growing our staff base and increasing the support we provide to our members through a suite of impactful activities online and in-person. Week after week, we have helped and supported members increase their ability to drive change at a national level, engaged partners in our cancer control priorities, and delivered impact in key global fora.

In 2025, we developed and published a 2025-2028 Business Plan, setting out our priorities and areas of focus for the next four years. In addition to improving our services to UICC members, we have identified people-centred care, lung cancer, women’s cancers, medicines access in LMICs, and improving health systems for cancer control, as areas in which the UICC team can play a unique role with partners, impacting the global challenges we face in each of these areas. Our partners have been extraordinarily supportive and provided us with the energy and funding to take each of these challenges forward with confidence.

As highlighted by Ulrika in her foreword, we organised the inaugural Cancer Planners Forum in 2025, bringing together 40 government officials to discuss cancer control planning and exchange best practice. The Forum proved so successful that we have a second Forum running in 2026 and I anticipate this event becoming a regular feature in the UICC calendar, complementing the biennial World Cancer Congress and the World Cancer Leaders’ Summit. Our ability to bring the cancer community together is critical to the success of our organisation and such interactions inperson cannot be replicated easily through online meetings.

As ever, the UICC team in Geneva and our army of volunteers who work with us every day have remained focused on what is important to our membership. This report summarises the work which has been delivered and the impact it has had. For such a small team, we achieve so much. We are blessed to be led by an outstanding Board of Directors and Ulrika Kågström, our President. I would like to thank the UICC team, the Board, and Ulrika for their energy and commitment in 2025, making it a pleasure to be the CEO of such a wonderful organisation.

Dr Cary Adams Chief Executive Officer, Union for International Cancer Control

Our mission

UICC unites and supports the cancer community to reduce the global cancer burden, to promote greater equity and to ensure cancer control continues to be a priority in the world health and development agenda.

Supporting members around the world

Members drive UICC’s priorities, inspire the action, and are central to everything UICC does. In 2025, UICC welcomed 55 new member organisations, bringing the total number to 1,132 across 172 countries and territories. Most new members are full members, representing Asia-Pacific and Europe. They indicate a strong interest in learning and development opportunities and in events such as the World Cancer Congress.

Of the 1,132 organisations with membership of UICC, 501 were full members with rights to vote at the UICC General Assembly and for their CEOs to attend the World Cancer Leaders’ Summit, 161 were associate members and the remaining were global network members.

Building on the successful launch of the membership centricity initiative, UICC renewed its focus on delivering value to members by prioritising their needs while continuously strengthening member services. Significant progress in membercentric communications, including the launch of the UICC Member Insider newsletter, a notable increase in the number of articles on our website based on interviews with our members, and social media engagements, have largely contributed to increasing the visibility of members across UICC’s network.

“UICC represents a global network of excellence and collaboration. For Hospital Moinhos de Vento, being part of UICC means having access to cuttingedge knowledge and information, and it reflects a collective commitment to improving cancer care. It strengthens our mission to bring the best in oncology to our patients in Brazil.’’

Luiza Abdalla, Strategy and New Business Manager, Hospital Moinhos de Vento, Brazil

“As an oncology society from a low- and middleincome setting, AMPOK has found UICC membership invaluable in connecting our clinicians and researchers to a truly global community. (...) Through access to UICC’s educational resources, thematic webinars, and the World Cancer Congress platform, our members are able to learn from best practices across regions. This engagement has strengthened our advocacy for equitable cancer care (...) Looking ahead, we see UICC as a vital partner in scaling our cancer control innovations (...)”

Association of Medical and Pediatric Oncologists of Kerala (AMPOK), India

172 countries and territories

1,132 members

“UICC’s strength lies in its members. Through active engagement, shared knowledge and collaboration across regions, our membership community continues to shape a stronger and more united response to cancer worldwide.”

Zainab Shinkafi-Bagudu, President-elect, UICC

Supporting members through exclusive learning and development opportunities

UICC’s learning and development opportunities supported 1,637 individuals from 910 organisations across 146 countries, of which 927 individuals (57%) and 356 organisations (39%) were UICC members.

In terms of membership type, the full and associate members engaged in 2025 represent over half (54%) of total full and associate members in the UICC membership in 2025.

Member engagement at key events

“It’s a vital role that UICC plays in connecting us with international communities. If you want to advance cancer control as one of your main objectives, it is better to join UICC and work together.’’

Mohammad Syafiq Abdullah, Director, Brunei National Cancer Center, Brunei

UICC’s participation in both in-person and online events has broadened its engagement with diverse membership communities. Through its partnership with the Economist Impact, UICC hosted a networking event at the World Cancer Series Europe in Brussels (10–11 June), which attracted new members and strengthened UICC’s visibility among European stakeholders.

Another milestone was the gathering of UICC members at the National Cancer Congress Malaysia (20–22 June). In collaboration with the National Cancer Society of Malaysia, UICC convened a session with 30 members from 14 Asia-Pacific countries, fostering new relationships, strengthening collaborations, and contributing to renewed engagement in rethinking the World Cancer Declaration.

The AORTIC 2025 Conference in Tunisia offered UICC a significant platform to deepen engagement across Africa and the Eastern Mediterranean, with over 150 conference delegates joining discussions at the UICC booth. Strategic connections were made with prospective members, civil society groups, hospitals, and research centres. The conference showcased strong momentum for regional collaboration and opened promising avenues for new partnerships.

The World Cancer Leaders’ Summit in Melbourne, a flagship event for full members, attracted more than 120 UICC member participants, reaching higher figures than the previous World Cancer Leaders’ Summit 2023 in in Long Beach, California.

Member Lens - developing a member-centred data culture

The first phase of Member Lens, a membership data project, was successfully completed. The aim is to establish reliable membership information to improve targeted outreach efforts. Findings of the initial phase enabled UICC to address foundational requirements for the management of the Customer Relationship Management (CRM) platform.

“Unicancer brings together France’s Comprehensive Cancer Centres around a unique not-for-profit model, combining care, research, innovation, and education within a shared ambition: improving outcomes for patients. Through our collaboration with UICC, we are pleased to contribute this collective expertise to the global cancer community, while learning from the diversity and strength of UICC’s international network.’’

Sophie Beaupère, CEO, Unicancer, France

UICC Connect

UICC Connect is the global community platform purposebuilt for cancer professionals and organisations to meet peers, learn together, exchange practical knowhow, and turn ideas into impact across programmes, geographies, and the full continuum of cancer control. It offers thematic rooms, member exclusive learning and content, and structured spaces that extend UICC convenings and advocacy into year-round collaboration.

“Coming from a non-medical background, UICC Connect has been transformative. It gave me access to courses, resources, and practical tools, helping me grow, learn from global peers, and strengthen my advocacy. The platform turns isolation into connection and learning into action, building confident individuals who drive stronger, more equitable cancer systems.”

Nadine Saadeh, Project Manager, Barbara Nassar For Cancer Patient Support, Lebanon

“A platform like UICC Connect can be incredibly valuable for sharing knowledge, best practices, and experiences with professionals across the globe. It fosters collaboration, learning, and support within the cancer care community, helping advocates like me strengthen our impact and bring better resources and hope to patients.”

Suchismita Das, Patient Advocate, Lung Connect India Foundation, India

Over 2025, UICC Connect consolidated its position as the online community platform for cancer professionals globally in its first full year of operations since the public release in September 2024:

→ Over 1,000 new users signed up

→ A total of 1,277 cancer professionals engaged with the platform

→ 802 (63%) of the users active in 2025 were UICC members, representing 323 member organisations

→ An average of 377 users logged in to UICC Connect every month, with approximately 50% of these being returning users

While the platform is open to anyone working professionally in cancer control, outreach is targeted predominantly at UICC members. Member organisations and their affiliates have exclusive access to online courses as well as to premium content and rooms. By the end of 2025, the platform had hosted 15 public discussion rooms (i.e. visible and accessible by all users), and seven private discussion rooms (i.e. accessible by invited users).

To nurture engagement among users, Connect Live sessions were launched in the last quarter of 2025. These are regular Zoom meetings designed to foster a sense of community, create connections and share ideas among UICC Connect users around broad themes. By the end of the year, three Connect Live sessions had been hosted, bringing users together on topics such as childhood cancer, breast cancer, and people-centred care.

Online learning

Overall, 283 individuals from 164 organisations took part in UICC’s online courses in 2025.

More than 97% of respondents of the satisfaction survey reported improved knowledge, and approximately 90% of respondents expressed a level of confidence in applying the knowledge acquired.

Two live, cohort-based, courses were offered to UICC members on the UICC Connect platform:

→ Advocacy for Improved Cancer Control (run in English, French and Spanish from March to June)

→ Women, power and cancer: Implementing the Lancet Commission’s recommendations (run in partnership with the McCabe Centre for Law and Cancer and members of the Lancet Commission from April to July)

An additional five courses were available in 2025 on demand as selfpaced courses on UICC Connect:

→ Engaging with law and policy for cancer prevention and control

→ The Cervical Cancer Elimination Initiative foundational course

Online courses offered ‘live’ on UICC Connect are complemented by dedicated discussion rooms, live faculty-led sessions and interactive discussions and assignments. Following the course, the prerecorded material is made available to all members on UICC Connect in a self-paced format, enabling those who may have not been able to complete the course during its live iteration to complete the learning on demand.

→ The Global Breast Cancer Initiative foundational course

“Almost all modules are relevant to my organisation effort in supporting the MOH of the Republic of Indonesia in developing its National Action Plan for Breast Cancer.”

Budiastuti Wening, Vice Chairperson, Indonesian Breast Cancer Foundation, Indonesia – participant in the Advocacy for Improved Cancer Control course

→ The Global Initiative for Childhood Cancer foundational course

→ Management essentials for civil society organisations in the cancer control space (available in English, French and Spanish)

A variety of self-paced courses are also available to members on UICC Connect, including foundational learning opportunities on the three WHO Global initiatives for childhood cancer, breast and cervical cancer.

“This was a very enlightening course. I thoroughly enjoyed the flow of the modules and speakers. Bringing the gender lens into the cancer space is a game changer and am already thinking of strategies to use to highlight this in our advocacy.”

Karen Nakawala, Executive Director, Teal Sisters Foundation, Zambia –participant in the course, ‘Women, power and cancer: Implementing the Lancet Commission’s recommendations’

Organisational leadership

In 2025, UICC continued to support UICC member organisations with learning and training opportunities to help strengthen the functioning and sustainability of their organisation.

The online course ‘Management essentials for civil society organisations in the cancer control space’, covered key organisational domains, from governance to strategy, communications to fundraising, and financial management to HR. Structured over eight modules, the course was made available to members in self-paced mode on UICC Connect.

Additionally, in support of the women’s cancers thematic priority, 12 member organisations working across breast and cervical cancer were offered one-onone guidance and support from expert mentors to help them tackle specific management and organisational challenges, identified through a structured selfreflection process.

To nurture peer-learning and accountability, individuals were invited to join a discussion room on UICC Connect dedicated to organisational strengthening. The room offers a space for the mentees to share progress, experiences, challenges, tips, tools and resources towards making their organisations, programmes or teams stronger, more efficient and sustainable.

Finally, also in support of the women’s cancers theme, in July, UICC hosted a three-part online workshop series on storytelling skills to drive action and change in support of 11 health professionals, advocates, patient leaders and researchers working on driving cervical cancer elimination efforts and scaling up HPV vaccination in their countries.

“I am going to use what I learned in my work to ensure HPV vaccination uptake in Ghana and also advocate for cervical screening in rural communities.”

Rukaya Mumuni, Principal Nursing Officer, Ghana Health Service, Ghana

Scholarships

UICC Scholarships, formally established in 2024, build on years of experience providing travel grants. They offer support towards travel, accommodation, and living expenses as well as visa costs where applicable. Priority is given to representatives of UICC member organisations from low- and middle-income countries. Through its Scholarships initiative, UICC aims to enhance equity and diversity at cancer control events, both in participation and in the views represented in discussions and content.

Overall, 86 scholarships were awarded in 2025 to 80 individuals across 49 countries to support their participation at eight different events, including two UICC-led events: the inaugural Cancer Planners Forum in Geneva in May and the World Cancer Leaders’ Summit in Melbourne in November. Other events included the 2025 Global Cervical Cancer Elimination Forum in Bali, Indonesia, WHO Regional Committee Meetings for the African, Eastern Mediterranean, and Western Pacific regions, and the International Conference on Cancer in Africa (AORTIC) in Tunisia in November.

It is also important to note that through the initiative and support of the National Cancer Society Malaysia (NCSM), UICC was able to invite an additional 30 individuals from UICC member organisations in the region to participate in the National Cancer Congress in Kuala Lumpur in June 2025, receiving travel grants administered and funded by NCSM.

“Receiving this scholarship has been an incredible journey, one that has broadened my perspective, connected me with inspiring experts, and empowered me to contribute to impactful cancer control initiatives. The support has been truly transformative, opening doors I never imagined.”

Abdullah Matouq, Ministry of Health, Jordan attended the inaugural Cancer Planners Forum, held in Geneva, Switzerland, 14 - 16 May

National Cancer Congress Malaysia

Strengthening national advocacy

Throughout 2025, UICC has continued to support its members in national advocacy for cancer control. 91 individuals completed the Advocacy for Improved Cancer Control course, in either the live or self-paced format. It incorporated two newly launched resources linked to WHO frameworks: the Breast Cancer Advocacy handbook, developed in 2024; and the Cervical Cancer Advocacy handbook, launched in 2025. A Virtual Dialogue held in July marked the launch of the Cervical Cancer Advocacy handbook and showcased examples of UICC members advocating for cervical cancer elimination in different resource settings across the world. Both handbooks are currently available in English, French, and Spanish.

Following completion of the 2025 live advocacy course, UICC opened the call for applications for the Cancer Advocates Programme. The 2025–2026 cohort includes 18 new organisations from 14 countries across Africa, the Eastern Mediterranean, Asia Pacific, and Latin America. Their advocacy projects address a wide range of priorities, including cervical cancer prevention and early detection, breast cancer screening, treatment and support, strengthening health systems, people-centred care, and the engagement of people with lived experience.

In parallel, UICC continued to implement dedicated advocacy projects through strategic partnerships. UICC completed a two-year partnership with L’Initiative to support civil society organisations in Francophone Africa. The programme culminated in a series of sessions to support organisational leadership, and in-person peer visits to foster exchange between members. To support civil society in the Indo-Pacific, in line with the Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC) partnership, UICC provided different types of support fostering the development of regional relationships, valued particularly due to the isolated nature of their respective roles with starkly similar geographic contexts and challenges, and networking opportunities with other key partners. At the World Cancer Leaders’ Summit, three of these members spoke on a panel about addressing cancer, notably cervical cancer, in small island states.

In East Africa, UICC and Cancer Research UK continue to support coalitions of civil society organisations in advocating for tobacco control, with significant wins in both Uganda and Kenya in 2025.

“It was a pleasure to take part in the advocacy session, we learned a great deal about fundraising. Following the training, we adjusted our approach and were able to secure two grants from ABC Global Alliance. I also drew on my own lived experience expertise as a former cancer patient to adapt our pitch and create impact.”

Ibrahima Madougou Moubarak, Founding President, Ligue Nigérienne de Lutte contre le Cancer, Niger

Fellowships

The 2025 call for UICC Technical Fellowships was open between JuneAugust, including the French and Spanish sub-programmes for Francophone Africa and Latin America. A total of 110 applications were received from 37 different countries.

31 fellowship awards were made to applicants from 23 countries, with Fellows hosted by 18 institutions across 11 countries. More than 50% of fellowships involved UICC member organisations as the home or host institution, and 35% of awarded Fellows are employed by UICC member organisations.

In collaboration with two UICC member and partner organisations, National Cancer Center Korea and Princess Margaret Cancer Centre, eight fellowships were awarded to visit these leading comprehensive cancer centres. Additionally, nine Fellows will visit IARC in Lyon, partly through the UICC-IARC Development Technical Fellowships.

As part of the dedicated and long-term partnership with UICC Japan, four YY Study Grants were also awarded in 2025 to researchers from Argentina, India, Nigeria and Pakistan wishing to visit Japan, Spain, the United Kingdom and the United States.

The annual YY Study 2025 Grant call closed on 17 November, with 15 applications received. Awards will be attributed in early 2026.

“My fellowship experience will equip me with advanced record linkage methodologies and practical insights into integrating screening data with cancer registry systems. These learnings will directly strengthen data quality, early detection efforts, and evidence-based decisionmaking at the Lilongwe Cancer Registry—ultimately contributing to more effective cancer control strategies across Malawi and the region.”

Frank Nkhwazi from Kamuzu Central Hospital and National Cancer Center, Malawi will visit the Ministry of Health, South Africa in 2026.

Awarded Fellows from UICC members

Universiti Malaya and Dharmais Cancer Centre, visiting the National Cancer Centre Korea, also a UICC member

World Cancer Leaders’ Summit 2025

Leaders and senior executives of UICC full members were invited to attend the 2025 World Cancer Leaders’ Summit, which took place from 18 to 20 November in Melbourne, to explore opportunities for ‘Bridging Divides, Building Futures’. The Summit brought together over 408 leaders from 55 countries, including UICC partners and member organisations such as cancer societies, research and cancer centres, and professional associations, to encourage timely debate on emerging global issues in cancer control. It was co-hosted by Cancer Council Victoria, the Victorian Comprehensive Cancer Centre Alliance, the Monash Comprehensive Cancer Consortium, the McCabe Centre for Law and Cancer, and the Melbourne Convention Bureau, continuing Australia’s longstanding commitment to supporting progress and collaborations on cancer control.

Ulrika Årehed Kågström, UICC President, opened the Summit and welcomed delegates, acknowledging the challenging geopolitical and social context, while emphasising that this uncertainty must not be interpreted as a lack of progress or hopelessness. Instead, she highlighted the negotiation of new global targets on noncommunicable diseases and the strengthened focus on cancer within the draft UN Political Declaration on NCDs and Mental Health as evidence of continued governmental commitment to cancer control. As the cancer community looks to implement the Political Declaration, she stressed the need for accountability and collective action. To support this, she highlighted the launch of the World Cancer Declaration 20252035, which consolidates insights from more than 100 UICC member organisations into a shared framework for action.

“Let us take the momentum from Melbourne and transform ideas into action. Our responsibility is now driving innovation, advancing equity, and delivering meaningful progress for every community we serve.”

Ulrika Årehed Kågström, President, UICC

“This is our moment to accelerate progress together, to connect, collaborate and elevate our ambition to match the scale of the challenge. The path in cancer control is not always smooth, and we may need to shift gears, but momentum is on our side. Powered by new knowledge, innovation and shared purpose, we can turn opportunity into lasting change and ensure that no one, anywhere, is left behind.”

Todd Harper AM, CEO, Cancer Council Victoria, Australia

at a glance

408 participants and 108 speakers

211 organisations from 55 countries

32 scholarships for UICC members from 22 countries

44 sessions, 4 networking receptions, 3 guided tours and 2 workshops

136 leaders committed their organisation to support the new World Cancer Declaration

“As a first time participant at the Summit, it was an honour to represent my small Pacific island nation. I was struck by the progress made in higherincome countries, yet it became clear that many of our challenges remain the same. With Australia as host, it was an important opportunity to put Pacific realities and the unique obstacles our island states face centre stage. My three days at the Summit prompted a fresh reflection on the direction of the Fiji Cancer Society for 2025 and reinforced a shared conviction among colleagues from Samoa, Vanuatu and Papua New Guinea: no island state should be left behind. Equity in Pacific cancer care is non-negotiable.”

Belinda Chan, CEO, Fiji Cancer Society, Fiji

World Cancer Declaration

The World Cancer Declaration 2025-2035 was successfully launched at the World Cancer Leaders’ Summit in Melbourne after a series of engagement opportunities with members that began at the Summit in Long Beach in 2024. UICC President Ulrika Årehed Kågström presented the updated World Cancer Declaration , highlighting its ‘5x5x5’ agenda endorsed by member organisations from around the world. A subsequent member panel on regional perspectives showcased how the Declaration supports real-world progress. Across regions, speakers affirmed the Declaration’s role in promoting accountability, shared targets, and collaborative innovation. Closing the Summit, the UICC President underscored the importance of global unity amid uncertainty, and encouraged participants to use the Declaration as a catalyst for international collaboration and national-level action.

“5 × 5 × 5 by 2035”

Framework

ELLOK proudly endorses the World Cancer Declaration 2025–2035. We share UICC’s commitment to a future where every person, regardless of background or geography, has equitable access to prevention, early diagnosis, treatment, and support. Putting patients and their lived experience at the centre of cancer policy is the surest way to turn vision into lasting progress.

George Kapetanakis, President, Hellenic Cancer Federation (ELLOK), Greece

Basic Health International is honored to support the UICC World Cancer Declaration 2025. Our work to eliminate cervical cancer through research, education, and the implementation of accessible care reflects the Declaration’s call for global equity in cancer prevention and treatment. Together with UICC and partners around the world, we are committed to reducing the global cancer burden and ensuring equitable access to prevention, treatment, and care for all.

Eveline Mumenthaler, Chief Operating Officer, Basic Health International, United States

Guided by equity, collaboration, evidence, sustainability, and accountability, and through coordinated action across countries and sectors, we can accelerate progress toward a future where every person, everywhere, has access to quality cancer prevention, treatment, and care. Baheya Foundation endorses and is committed to achieving World Cancer Declaration 2035 targets.

Yomna Sherif Omara, Breast Surgeon, Patient Navigation Programme Manager, Baheya Foundation, Egypt

World Cancer Declaration 2025-2035

Hospital Moinhos de Vento

Member engagement in 2025

In 2025, UICC has tracked individuals and organisations that were engaged or supported through the work outlined in this report. In total, 2,109 individuals from over 1,100 organisations across 156 countries were engaged, of which 1,179 individuals (56%) and 405 organisations (36%) were UICC members. Whilst member organisations may have had multiple touch points with UICC during a year, most of these member organisations have been supported via the learning and development opportunities provided, with 356 organisations reached through these activities alone.

The regional spread of the member organisations engaged was as follows:

“The support of the UICC empowers us to share our insights on the world stage, establishing our organization as a recognized thought leader and a peer among global institutions. This significantly enhances our reputation. Through sustained collaboration with aligned partners, we access cutting-edge knowledge, benchmark against the best, and systematically build our capabilities. In the end, this global engagement is itself a powerful form of leadership development, fostering greater confidence, cultural intelligence, and a forwardthinking, strategic outlook.”

Mary Wong, Global Chinese Breast Cancer Organizations Alliance, Hong Kong

In terms of membership type, the full and associate members engaged in 2025 represent over half (59%) of the UICC membership in 2025.

Lymphoma Action

Cancer Warriors Mexico

Increasing attention on people-centred care

In 2025, UICC consolidated and strengthened its focus on peoplecentred care, reflecting the strategic organisational priority in the Business Plan 2026-2028 and in line with related targets in the new World Cancer Declaration. This thematic alignment brings together long-standing efforts to support patient groups, elevate the voices of people with lived experience, advocate for equitable access, and reinforce synergies with the World Cancer Day campaign ‘United By Unique’. UICC leveraged the World Cancer Leaders’ Summit to highlight the topic with a dedicated peoplecentred care session designed to explore what people-centred care means both in practice and in policy.

In addition, UICC supported advocacy efforts on people-centred care through its work with members, including advocacy priorities such as integrating expertise from people with lived experience into health decision-making, mobilising youth and communities, increasing health literacy, and reducing stigma.

“La Roche-Posay stands with all people affected by cancer. While every cancer journey is unique, we are all united in ensuring that patients have access to comprehensive supportive care that can genuinely make a difference in their quality of life.”

Alexandra Reni-Catherine,

Global Brand General Manager, La Roche-Posay

Femama/IMAMA

Patient

Group Mentoring programme: Progress and impact

Throughout 2025, UICC continued to provide support and platforms for patient groups in its network to share progress and exchange experiences. The programme also continued to contribute to the growth and diversification of UICC’s membership, with two new organisations joining the African cohort. Throughout the year, member organisations achieved recognition for their work, including the Global Breast Cancer Organizations Alliance being presented with the Gold ‘Champion of Good Award’ recognising excellence in mental health support for breast cancer patients.

Results from the end of year survey highlight the programme’s strong impact on collaboration, capacity building, and leadership visibility.

→ 89% of respondents reported increased collaboration with the regional cancer community, while 81% indicated strengthened organisational and technical skills.

→ 67% reporting greater collaboration with the global cancer community.

→ 65% noted increased recognition of their senior executives as leaders within the cancer control space.

In 2025, 23 patient organisations were awarded scholarships to attend WHO Regional Committee meetings, AORTIC, and the World Cancer Leaders’ Summit enabling patient representatives to contribute their expertise directly to high-level discussions and programme sessions. The value of this approach was formally recognised by the WHO Regional Office for the Eastern Mediterranean, following the Regional Committee meeting, which acknowledged the impact of scholarship support provided to patient groups as part of UICC’s delegation in bringing recognition and ensuring representation of lived experience in this forum.

To further amplify the impact of patient-led initiatives aligned with the World Cancer Day campaign, five grants were awarded in 2025 to organisations in Morocco, Indonesia, Jordan, Lebanon, and the Philippines. These initiatives used storytelling, training, and creative community events to raise awareness and advocate for improved, people-centred cancer care.

Awarded fellow from UICC member, Uganda Child Cancer Foundation during a visit to St. Jude Children’s Research Hospital, also a UICC member

World Cancer Day

4 February

The first year of the three-year World Cancer Day campaign ‘United By Unique’ was a great success, demonstrating how deeply the new theme resonated with people in all countries. The campaign was created together with and for UICC members. It calls for a fundamental shift in cancer care and health systems worldwide towards a people-centred approach, which is oriented around individuals and communities instead of just the disease.

Every experience of cancer is unique, and it takes everyone, united, to create a world where care and support is personalised, compassionate, and accessible to all. The campaign explores different dimensions of people-centred cancer care and new ways of making a difference. UICC invited individuals from all walks of life to share their personal cancer stories to showcase real experiences with unique perspectives. Whether it is someone living with cancer, a family member, a caregiver, a medical professional, an advocate, or an ally, these stories show different people’s experience with cancer, the diverse challenges each faces, and how a people-centred approach to care could respond to their unique situations.

By bringing these stories together, the campaign built a rich collection of voices that serves as a striking illustration of what is meant by ‘United by Unique’: every person is one-of-a-kind, but no one is alone in their aim to take meaningful and lasting action to reduce the burden of cancer. It’s about recognising and validating each unique experience, and fostering a sense of community and shared purpose among those affected by cancer.

World Cancer Day 2025 generated high levels of engagement, with communities, organisations, and individuals embracing the campaign and adapting it to their local contexts in inspiring ways. Events took place around the world, including walks, talks, panel discussions, sales, petitions, workshops, and illuminated landmarks. Across countries, individuals and organisations celebrated the progress made and called for further efforts in cancer control.

SHAME COURAGE GRIEF LOVE DESPAIR STRENGTH

PAIN GRATITUDE ANGER

A look at World Cancer Day’s global reach

+ 900 ACTIVITIES IN 102 COUNTRIES

SIX BILLION IMPRESSIONS NINE MILLION ENGAGEMENTS + 600 STORIES IN TEXT, VIDEO AND ART FORM ON THE WEBSITE + 1,000 PEOPLE TOOK PART IN THE UPSIDE DOWN CHALLENGE ON SOCIAL MEDIA + 30,000 PRESS MENTIONS IN 162 COUNTRIES

530,000

WORLDCANCERDAY.ORG VISITORS

+300,000 CAMPAIGN VIDEO VIEWS ON YOUTUBE

As every year, World Cancer Day would not be possible without the efforts of UICC’s members and partners. The diverse membership community – from patient support groups to research and cancer centres, NGOs, professional associations –is at the heart of the campaign and drives forward action before and on 4 February through local, regional, and national events.

The feedback from UICC member organisations about the campaign was overwhelmingly positive, and the global World Cancer Day Impact Report 2025 illustrates the enthusiastic engagement of UICC members across the world.

“At Fujifilm, we are honoured to continue our collaboration with UICC, standing alongside people and communities worldwide in the fight against cancer. Through United by Unique, we recognise that every individual story matters, and by bringing these unique perspectives together, we can inspire real progress. We remain dedicated to advancing healthcare solutions that help create a future where no one is left behind.”

Masataka Akiyama, Managing Director, Fujifilm Europe

“At Sanofi, we recognise that every cancer patient is unique. We are inspired by their resilience in our mission to develop novel treatment options, expand access to therapies and provide comprehensive patient support resources. We are proud to be a partner of World Cancer Day and the United by Unique campaign to find solutions for the future of cancer care.”

Olivier Nataf, Global Head, Oncology Franchise, Sanofi

Shaukat Khanum Cancer Hospital

We thank our partners for their valuable support and contribution to World Cancer Day.

Visionary Partners

Growth Partners

Increasing attention on women’s cancers

Hospital Moinhos de Vento

In 2025, through UICC’s work on women’s cancers, 238 organisations and 353 individuals were engaged across the membership, reflecting the strong representation in UICC’s membership of organisations interested in this area, and the commitment to advancing breast and cervical cancer control globally.

Sustained advocacy efforts

UICC continued to play a central role in advancing breast cancer advocacy globally, working in close collaboration with WHO through its participation in the Global Breast Cancer Initiative Technical Working Group. This collaboration supported the co-development of key resources, notably a new policy brief on breast cancer, published during Breast Cancer Awareness Month, developed with the support of leading experts. The brief provides ministries and advocates with practical policy options to strengthen national strategies on breast cancer. UICC’s advocacy efforts also contributed to securing the inclusion of breast cancer in the 2025 UN Political Declaration on NCDs and Mental Health, following sustained engagement with members and diplomatic missions to strengthen the visibility of women’s cancers in global commitments.

On cervical cancer, UICC strengthened its support to advocates with the update of the Cervical Cancer Advocacy Handbook. Published in April, the handbook provides civil society organisations with practical guidance to translate the WHO Global Strategy’s 90-70-90 targets into effective national advocacy, offering adaptable messaging, coalition building tools and context-specific strategies for prevention, screening and treatment. It is available in English, French and Spanish.

Through its role in the Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC), UICC worked with civil society across many Pacific island countries such as Fiji, Vanuatu, Papua New Guinea, and Timor-Leste to support national advocacy efforts on cervical cancer. Organisations benefitted from tailored opportunities, including scholarships, networking, and mentoring, and received access to key advocacy resources.

Providing this support as part of the wider consortium of organisations in EPICC is bringing other opportunities to these civil society organisations, with the collective and coordinated efforts of all involved creating an optimal environment for progress towards elimination. Supported by Expertise France, UICC also continued to provide support to a group of civil society organisations in Francophone Africa on cervical cancer advocacy, following its work in prior years as part of the Unitaidfunded SUCCESS project, which was led by Expertise France and implemented in partnership with Jhpiego.

Supporting national-level implementation

Throughout the year, 10 UICC member organisations were supported via grants to implement projects to scale up access and increase uptake of HPV vaccination in their contexts. In total, UICC disbursed USD 200,000 to the grantees, who collectively achieved substantial reach and measurable progress. Their achievements further demonstrate the critical role of civil society in expanding HPV vaccination access, demand generation, awareness-raising, and driving progress toward the 90% vaccination target.

In addition, through the Reimagining Cancer Research in Europe initiative, UICC continued to support a collaborative implementation research project to support the use of HPV self-sampling in Ukraine to enhance cervical cancer screening given the conflict situation. Via the ATOM Coalition (see later), UICC has also enabled increased access to breast and cervical cancer diagnostics and treatment through its access pathways, and responded to country needs to strengthen breast cancer treatment, including the updating of clinical guidelines in Mongolia.

Learning and development

More broadly, UICC delivered dedicated training opportunities for civil society organisations working on women’s cancers. As part of this effort, a dedicated storytelling programme for 11 champions in women’s cancers (primarily focused on cervical cancer) strengthened their ability to communicate compelling narratives that drive advocacy, community mobilisation, and policy influence.

UICC also provided tailored mentoring in organisational leadership to selected member organisations engaged in women’s health. Building on UICC’s self-guided course ‘Management essentials for civil society organisations’, 12 organisations were selected to receive one-to-one mentoring from Stone Soup Consulting to strengthen leadership, governance and management practices.

An online course on ‘Women, power and cancer’ helped professionals better understand how gender and power dynamics shape cancer risks, access to care, workforce equity, and policy influence. Based on the findings of the Lancet Commission on ‘Women, power and cancer’, and developed with the McCabe Centre for Law and Cancer and members of the Lancet Commission, the course equipped participants with practical approaches to integrate a gender lens into cancer advocacy, planning and service delivery.

The inaugural edition brought together 87 professionals in a live format, creating a global community committed to advancing gender-responsive cancer control. Following this, the course was transformed into a self-guided course, now available on demand on UICC Connect.

UICC continued to offer foundational learning opportunities on the Global Breast Cancer initiative and the Global Strategy on cervical cancer elimination. In 2025, these were enriched with additional content on patient navigation, and the Cervical Cancer Elimination Planning tool developed by IARC and the University of Sydney launched in May 2025.

Key events

UICC leveraged key events to bring attention to women’s cancers, including at the Second Global Cervical Cancer Elimination Forum in Bali. This high-level gathering, cosponsored by the Governments of Indonesia, Spain and Australia and organised in partnership with WHO, Gavi, Unitaid, UNICEF, the World Bank, the Global Financing Facility and the Gates Foundation, brought together governments, international agencies, civil society and other stakeholders to accelerate action towards the 2030 targets for cervical cancer elimination. UICC led a session focused on advocacy, underlining the central role of civil society in influencing policy, holding governments accountable and supporting sustainability, issued a formal statement to reinforce its institutional commitment to cervical cancer elimination, and supported the participation of advocates from civil society organisations, ensuring that the perspectives and priorities of local organisations were clearly heard in the global conversation.

At the World Cancer Leaders’ Summit, UICC convened a focused workshop on increasing access and uptake of HPV vaccination, gathering representatives from 11 countries, including a number of project grant recipients, to examine progress, persistent barriers, and effective strategies. UICC also led a multi-sponsored session on advancing cervical cancer elimination, which explored progress towards the 2030 targets, and highlighted country experiences from Sweden, Nigeria, Indonesia and Fiji. Complementing these UICC-led sessions, partners emphasised women’s cancers through several other sessions.

Alongside these in-person events, UICC strengthened knowledge exchange and peer learning on women’s cancers particularly through a series of virtual events. Virtual Dialogues provided platforms for member organisations to deepen expertise and access practical tools. In April and May, sessions addressed priority needs identified by members: the first focused on breast cancer advocacy, supporting organisations to leverage the newly released Breast Cancer Advocacy Handbook; the second, delivered in partnership with Gavi, titled ‘Navigating Gavi: Supporting civil society organisations in advancing access to HPV vaccination’, directly responding to gaps highlighted in the 2023 landscaping study on the role of civil society organisations in HPV vaccination. Aligned with the publication of UICC’s updated Cervical Cancer Advocacy Handbook, a third global Virtual Dialogue, ‘Advocacy to Action: The role of civil society in cervical cancer elimination’, brought together UICC President Ulrika Årehed Kågström and civil society leaders from New Zealand and Malawi, enabling cross-regional reflection on effective advocacy approaches. Complementing these sessions, a UICC Connect Live event spotlighted lived experience and showcased the work of member organisations active in breast cancer, fostering community connection and peer learning during Breast Cancer Awareness month in October.

“Breast cancer is not only a health challenge; it is a societal and economic test that demands coordinated action across policy, care delivery, data, and financing. By working together, governments and partners across Southeast Asia can close long-standing gaps, strengthen solidarity, and build systems capable of giving every woman equitable access to timely diagnosis and treatment.”

Logan Caragata, Head of Policy, APAC Region, Roche

In memory of Ivone (1963-2025)

Improving health systems for cancer control

Cancer Planners Forum

National public health officials responsible for designing and implementing national cancer strategies and other health officials from around the world met in Geneva on 14-16 May for UICC’s inaugural Cancer Planners Forum. The event brought together more than 100 participants, including cancer planners from 40 countries – most of them from ministries of health – as well as representatives from WHO, IAEA, IARC, the International Cancer Control Partnership (ICCP), and other partner organisations.

Held just ahead of the World Health Assembly (WHA), the Forum focused on practical ways to improve cancer control plans used to guide cancer prevention, diagnosis, treatment, and care at the national, regional, state, and city levels.

The event programme comprehensively addressed the entire cancer planning process: setting objectives and identifying priorities, costing and financing, implementation, monitoring and evaluation, and engaging stakeholders. The event further highlighted the essential collaboration between international bodies and cancer organisations, and encouraged cross-border interactions as well as peer-to-peer support.

Participants engaged in rich discussions on national cancer control planning within the broader context of health systems, with a focus on advancing equitable cancer care in the years ahead. Sessions combined expert presentations, country-led case studies, and interactive roundtable discussions to promote learning and practical exchange.

A key focus was the importance of robust national data collection and ensuring alignment with broader health policies and universal health coverage goals. The event fostered dynamic exchanges and encouraged participants to connect with peers and experts from around the world, sharing ideas, approaches, and lessons learned.

“The cancer burden is rising and we urgently need new, collaborative solutions grounded in strong research and knowledge exchange. Data and robust cancer registration systems play a vital role in national cancer control planning.”

Elisabete Weiderpass, Director, IARC

“Even coming from a country with a well-established cancer control system, the Cancer Planners Forum offered fresh perspectives and meaningful dialogue. It was a reminder that no matter how advanced our programmes may be, there is always something to learn— from innovative approaches in other contexts to the resilience and creativity of planners working with fewer resources.”

Alicia Fernández Montero, Ministry of Health, Spain

“Some of the most well-written national cancer control plans have failed to improve the lives of people affected by cancer. With this Cancer Planners Forum, we mark a new era –one where success is not measured by printed words but by real impact and achievements.”

André

Ilbawi,

Technical Lead for Cancer Control, WHO

UICC supported national cancer control planning through coordinated technical assistance, convening, and policy-focused initiatives under the International Cancer Control Partnership (ICCP) and the Cancer Planners Forum.

The year started with the publication of the second Global Review of National Cancer Control Plans (NCCPs), published in The Lancet Oncology in January 2025, providing insights into the state of cancer planning worldwide.

Main conclusions from the review

→ There were improvements in some areas since the first review conducted in 2018. Notably, the inclusion of financing strategies in plans increased from 7% in 2018 to 27% in 2023.

→ Compared to the 2018 review, the 2024 analysis also showed significant progress in the specificity and integration of NCCPs. However, persistent challenges in resource allocation and equitable access to cancer services highlight the need for continued efforts to address these gaps.

→ Very few NCCPs included evidence-based recommendations for their strategies and interventions. Only 23% of NCCPs and 12% of NCD plans included an evidence base with references for some strategies, highlighting a significant area for improvement.

A highlight in 2025 was the launch of the redesigned ICCP Portal at the Cancer Planners Forum, a resource to support countries in strengthening their cancer control strategies. The platform is designed to foster knowledge exchange, promote evidence-based planning, and connect planners with practical solutions and global expertise.

Through the ICCP, technical assistance was delivered across multiple regions, including completed reviews of seven national cancer control plans (NCCPs) and the publication of additional reviews on the ICCP portal. Peer-to-peer learning was further strengthened through the ICCP ECHO programme, supporting six country teams via monthly sessions.

UICC also contributed to systems-level impact through the ATOM Coalition, finalising Mongolia’s country action plan to address barriers to access to cancer medicines and strengthen digital monitoring aligned with the national NCCP.

Advocacy efforts reinforced the role of NCCPs as a foundation for sustainable cancer financing and health system strengthening, complemented by national-level engagement through the Cancer Advocates programme, which continued to build civil society capacity to influence policy, monitor implementation, and engage in NCCP processes.

Addressing the growing threat of antimicrobial resistance

Addressing antimicrobial resistance (AMR) in cancer care emerged as a growing priority. UICC contributed to strengthening global awareness, policy engagement, and evidence-based data on the growing threat of AMR on effective cancer care. It notably elevated AMR within cancer policy dialogues through high-level side events held at the World Health Assembly (WHA) and the United Nations General Assembly (UNGA), a dedicated virtual dialogue, and sustained visibility across global conferences. This contributed to the explicit inclusion of cancer and AMR in the 2025 Political Declaration on NCDs and Mental Health.

Analytical work on the economic and health impact of AMR in cancer care was initiated to strengthen the investment case for infection prevention and access to effective antimicrobials for effective infection management. To support policymakers and the oncology health workforce, UICC published several key resources, including policy briefs for the oncology health workforce, “Addressing antimicrobial resistance in cancer care: the critical role of the cancer health workforce” and a resource for cancer planners and the cancer community, “Addressing Antimicrobial Resistance in Cancer Care: A Review of National Cancer Control Plans and Policy Recommendations”. Two articles published in The Lancet Oncology in May further amplified the urgency of integrating AMR considerations into cancer control strategies. The launch of the ICCP resource page on Cancer and AMR provided countries with practical tools to embed infection control and AMR strategies into national cancer control planning.

Engaging members and stakeholders in national cancer planning

UICC engaged members as active contributors to national cancer planning, policy dialogue, and implementation. Member expertise was mobilised through targeted policy outputs and global convenings, including a Pink October policy brief on equitable access to breast cancer care and dedicated NCCP-focused sessions at major events such as the World Cancer Leaders’ Summit and the AORTIC Conference. These platforms facilitated peer exchange, regional learning, and alignment between global guidance and countrylevel realities.

Building capacity for cancer registries and surveillance

UICC continued to support strengthened cancer data systems through collaboration with partners on cancer registries and surveillance. Key contributions included participation in the Global Survey of Registries, generating global insights into data challenges and needs, and ongoing capacity building through technical fellowships and training initiatives. These efforts supported LMIC professionals to apply epidemiological methods and strengthen the use of national cancer data for planning and policy.

Increasing access to medicines and technologies through the ATOM Coalition

Gavi/2025/Ajay Maharjan

2025 marked a year of consolidation and scale for the Access to Oncology Medicines (ATOM) Coalition, a UICC-led multi-stakeholder partnership working to expand equitable access to qualityassured cancer medicines and diagnostics in low- and lower-middle-income countries by addressing barriers across the oncology access continuum. Building on foundations laid since its launch in 2022, the ATOM Coalition advanced practical, country-centred solutions that move beyond commitments toward delivery –strengthening readiness, expanding access pathways, and deepening collaboration across governments, industry, technical agencies, and civil society.

Expanding access to cancer medicines and diagnostics

The ATOM Coalition made concrete progress in operationalising multiple access pathways –including indirect commercialisation, voluntary licensing, donation-based models, and pooled procurement – with 37 quality-assured medicines and 10 diagnostics available through Coalition pathways, of which 34 medicines are on the WHO Essential Medicines List and three are innovative therapies. Access expanded across countries, with five countries now purchasing medicines, and two innovative medicines newly available on NCDconnect. Overall, medicines delivered through ATOM Coalition pathways reached close to one million doses in 2025, representing an estimated 11,000+ patients reached based on standard treatment assumptions.

The Coalition also advanced several important proof-of-concept initiatives. This included further progress on the nilotinib voluntary licence as the ATOM Coalition’s first oncology licensing model. The Coalition helped build the systems and partnerships needed for countries to access, receive, and use quality-assured generic nilotinib for chronic myeloid leukaemia (CML), while also generating important lessons for future licensing approaches in oncology.

In parallel, the ATOM Coalition secretariat worked with BMS to expand access to nivolumab in eight countries – Côte d’Ivoire, Ethiopia, Kenya, Pakistan, Rwanda, Tanzania, Uganda, and Zambia – while also beginning to test a scalable model for strengthening health system readiness to receive and use immunooncology products in five countries: Ethiopia, Kenya, Rwanda, Uganda, and Zambia.

The ATOM Coalition also successfully negotiated access to precision and mRNA based cancer diagnostic tests. ATOM Coalition partner Cepheid, a diagnostics company, agreed to offer cancer diagnostic and monitoring cartridges to all 46 ATOM Coalition countries at a global access price ex-factory of USD 50 per test. These tests cover chronic myeloid leukemia (CML), cervical, and bladder cancer. Complementing improved access to medicines with the diagnostics needed to guide and monitor treatment represents an important step towards more complete cancer care.

Country implementation and capacity strengthening

Building on the momentum established in 2024, the ATOM Coalition significantly advanced its country engagement and capacity-strengthening model across Africa, Asia, and Latin America. What began with early partnership formalisation and situational analyses in countries such as Mongolia, El Salvador, and Zambia evolved into more concrete implementation planning, technical prioritisation, and targeted support. The Coalition continued to formalise collaboration with Ministries of Health and national cancer institutions, deepen baseline assessments of regulatory, supply chain, pathology, and clinical readiness, and align country support through workshops and multistakeholder consultations. These efforts further reinforced the Coalition’s countryled, demand-driven approach and helped refine the operational model for broader scale.

In Mongolia, progress moved from assessment and prioritisation to implementation readiness: the revision of national breast cancer guidelines was completed in line with ASCO (American Society of Clinical Oncology) recommendations, including an updated list of recommended medicines incorporating innovative therapies.

Building on this, a Multidisciplinary Cancer Management Course was developed with ASCO to support dissemination and practical uptake of the revised guidelines. In El Salvador, the situational analysis process culminated in a completed three-year action plan focused on biosimilar regulation, hospital registry data quality, and pathology capacity, with implementation activities now being developed alongside Coalition partners. Zambia moved beyond baseline assessment to complete national laboratory infrastructure mapping using the ASCP (American Society for Clinical Pathology) benchmarking tool, laying the groundwork for pathology guidelines, workforce certification, and better equipment allocation, while also beginning work with the Ministry of Health to strengthen oncology medicines forecasting.

The Coalition also expanded into new and more advanced phases of engagement in other countries. In Uganda, the team secured government commitment to formal collaboration through the Memorandum of Understanding process and prepared to launch the situational analysis and national workshop in 2026.

In Indonesia, a collaborative agreement was signed with the National Cancer Center, Dharmais Cancer Hospital, to strengthen access to quality-assured CML medicines, diagnostics, and monitoring tools, with priority barriers already identified and validation of capacitystrengthening activities underway. Across five countries in sub-Saharan Africa, the ATOM Coalition developed a regional capacity-strengthening plan to support the introduction of immune checkpoint inhibitors, including work on diagnostics, appropriate clinical use, financing, patient tracking, and monitoring and evaluation; readiness assessments were completed in Rwanda, Uganda, and Zambia. Initial engagement also began in Honduras, while in Ethiopia high-level discussions advanced on both CML and immuno-oncology readiness. Together, these developments show how the ATOM Coalition’s capacitystrengthening model continued to mature in 2025 – moving from early proof of concept to more structured, countryspecific implementation and regional scale-up.

Aga Khan Hospital

Health financing

In Zambia, ATOM advanced two health financing technical assistance projects, both expected to conclude in Q1 2026. The first focused on improving the timely and cost-effective procurement of oncology medicines, including assessment of a potential pooled procurement model. Findings shared with the country coordination mechanism in November showed progress in forecasting but also highlighted persistent gaps in budget planning and procurement, contributing to an estimated annual funding shortfall of USD 6 million for oncology medicines. A complementary assessment by IDA Foundation found that pooled procurement through NCDconnect could generate nearly USD 900,000 in savings in 2025, equivalent to around 19% savings for the Ministry of Health, creating opportunities to reinvest in additional medicines and diagnostics.

The second project supported the Cancer Diseases Hospital in designing more sustainable financing mechanisms for equitable access to innovative cancer therapies, with a particular focus on immune checkpoint inhibitors. The design of a revolving fund model combining private insurance contributions and, over time, public financing was completed, with implementation planned for 2026.

In collaboration with ATOM Coalition partners in 2025:

Led by

Coalition

Increasing attention on lung cancer

The adoption of the WHO Integrated Lung Health Resolution at the 78th World Health Assembly (WHA) in May 2025 represented a major milestone for global lung cancer and lung health advocacy. This achievement followed two years of sustained engagement with Member States and UICC members. Throughout the negotiation process, UICC played a visible and consistent role in convening stakeholders and ensuring that lung cancer was strongly reflected in the final resolution, which encompasses several communicable and non-communicable lung diseases.

During WHA, UICC co-hosted a high-profile side event with the Malaysian Ministry of Health, which spotlighted the importance of integrated approaches to lung health across the continuum of care. This event brought together Member States, UN agencies, and UICC members and partners to discuss practical implementation of the resolution at national level, reinforcing UICC’s role as a convener and advocate for evidence-based policy action.

UICC’s contribution to shaping global guidance also continued through its support to the IARC Handbook 21, which will provide evidence-based guidance on lung cancer screening.

This work is expected to inform national screening strategies and strengthen the global policy environment for early detection once the Handbook is released in Q2 2027.

Leveraging global events

UICC maintained strong visibility at major global events, including the World Conference on Lung Cancer, the World Cancer Leaders’ Summit, the 11th Session of the Conference of the Parties (COP11) to the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), and the London Global Cancer Week – where UICC highlighted the need for multisectoral collaboration and the importance of moving from adoption to implementation of the resolution.

Member engagement on lung cancer significantly increased during the year. UICC launched a dedicated UICC Connect room to share knowledge and best practices, as well as strengthen collaboration among members working on lung cancer. This was complemented by a coordinated communications outreach aligned with key awareness dates –including World Lung Cancer Day and Lung Cancer Awareness Month – which helped amplify member activities and raise the visibility of lung cancer across UICC’s platforms.

Collectively, these activities contributed to greater awareness, stronger member collaboration, and improved knowledge exchange across the UICC and broader cancer control community, helping to drive global momentum on lung cancer and advocate for integrated lung health within the evolving global health agenda.

Tobacco control

UICC’s tobacco control advocacy centred on engagement in the WHO FCTC COP11, where UICC participated as an accredited non-government organisations observer and played an active role. UICC was joined by several member organisations as part of its official delegation – Breast Care International (Ghana), the Danish Cancer Society, the Canadian Cancer Society, the Norwegian Cancer Society, Cancer Survivors Malaysia, and the International Institute for Legislative Affairs (IILA, Kenya) – as well as its sister organisation, the McCabe Centre for Law and Cancer. Their participation ensured that diverse regional perspectives and country-level experiences were well represented.

To advance shared priorities, UICC led or co-hosted a series of side events focusing on key issues such as tobacco taxation, implementation of FCTC guidelines, and the integration of tobacco control within the broader lung health agenda. Over the course of the Conference, UICC jointly delivered seven statements, advocating inter alia for stronger liability mechanisms, more innovative regulatory measures, and reinforced protections from tobacco industry interference.

These interventions contributed to a cohesive civil society voice and helped maintain momentum on critical articles of the FCTC. UICC also contributed to preparation efforts for COP11, including an advocacy briefing meeting for Geneva based Permanent Missions to highlight policy asks and emerging risks.

Beyond global negotiations, UICC continued to strengthen tobacco taxation work with Cancer Research UK in Kenya and Uganda, where national coalitions made notable progress. Both coalitions conducted policy research assessing strengths and gaps in current tobacco control and taxation frameworks. In Kenya, several coalition members –including IILA and the Kenya Network of Cancer Organizations, UICC members - participated in a workshop on tobacco industry interference, enhancing their ability to identify and counter common industry narratives. In Uganda, coalition representatives – including the Uganda Cancer Society, a UICC member - took part in the University of Cape Town training on developing a TetSim Model to support stronger, evidence-based taxation proposals.

In April 2025, these efforts culminated in a unified civil society proposal submitted to Uganda’s Parliament, calling for the doubling of cigarette excise taxes, a singletier tax structure, and annual increases indexed to inflation and income levels. While the proposed doubling was adopted for imported cigarettes, tax adjustments on locally manufactured products remained limited, highlighting the need for continued advocacy. Both coalitions received support from UICC to strengthen communications and advocacy efforts, and to learn from other organisations. They developed their own communications and advocacy materials tailored to policymakers, media, authorities, and the public, helping to broaden understanding of tobacco taxation and its public health benefits. In addition, they convened stakeholder dialogues to raise awareness, strengthen national partnerships, and support coordinated action on tobacco control.

© WHO / FCTC / Pierre Albouy

Air pollution

UICC advanced its work on air pollution and cancer, focusing on consolidating the evidence base and building its influence within global health and policy spaces. UICC notably developed two key reports, the core deliverables of the Clean Air Fund grant. The first report, developed with The George Institute and UICC’s Expert Taskforce, synthesises the evidence linking air pollution exposure with cancer incidence and mortality, aiming to provide an accessible entry point and key messages for cancer advocates. The second report builds on this evidence to outline practical policy options that UICC members and governments can champion to reduce air pollution and protect current and future cancer patients. Both are planned to be launched in 2026.

Alongside these technical outputs, UICC deepened its engagement with the global clean air community. UICC was invited to join a WHO-Civil Society working group to develop the call to action for the Second WHO Global Conference on Air Pollution and Health in Cartagena, Colombia, as well as attending the conference itself.

Building on these connections, UICC supported advocacy for the adoption of the updated WHO Roadmap on Clean Air at the World Health Assembly, including the new target of a 50% reduction in premature deaths from human-caused air pollution by 2040; alongside working with partners to secure clean air language in the 2025 Political Declaration on NCDs and Mental Health.

Increased impact for cancer control through multi-sectoral partnerships

UICC remains committed to building and nurturing mutually beneficial partnerships that amplify its impact and advance progress in global cancer control. It continued long-standing collaborations with partners such as Pfizer, AstraZeneca, The University of Texas MD Anderson Cancer Center, MSD, and La RochePosay. UICC also welcomed new partners, including Novo Nordisk, Mayo Clinic, Novocure, and Regeneron. Over 80 partners contributed either financial or in-kind support to UICC in 2025.

The World Cancer Leaders’ Summit once again proved a key event on the calendar for companies and organisations, with new sponsors joining including Microsoft, Exact Sciences, IOZK and Peter MacCallum Cancer Centre.

To continue building on existing partnerships and engaging new partners, in-person meeting opportunities were leveraged wherever possible to strengthen partnerships, with UICC representatives attending key events in the oncology and global health space, including World Health Assembly, ASCO, UNGA and ESMO.

Bristol Myers Squibb (BMS) once again organised the C2C4C (Country 2 Country 4 Cancer and Continent 2 Continent 4 Cancer) rides in Europe and Latin America to raise awareness and funds benefiting UICC member organisations in these regions. For the first time in 2025, the C2C4C Japan edition also joined forces with UICC to support its members in the Asia Pacific region with 55 BMS employees cycling approximately 1,800 kilometres in a mountain loop through the heart of Japan, starting and ending in Tokyo. Together, these three rides, with BMS providing additional donations, raised over USD 700,000, going directly to UICC members in the respective regions to support locally delivered cancer control activities.

2025 saw the first of the three-year ‘United by Unique’ World Cancer Day campaign which was supported by longstanding World Cancer Day partners: Amgen, Boehringer Ingelheim, Fujifilm, La Roche-Posay, MSD and Roche. The campaign also welcomed new World Cancer Day partners: AbbVie, Jazz Pharmaceuticals and ONO Pharma.

Strengthening UICC’s work on cervical cancer, in 2025, UICC continued to receive support from key institutional partners, including Expertise France, the Gates Foundation and through the ‘Elimination Partnership in the Indo Pacific region on cervical cancer’ (EPICC) funded by the Department for Foreign Affairs and Trade of the Australian Government, and led by the University of Sydney.

The inaugural edition of the Cancer Planners Forum in May 2025 was strongly supported by UICC members and partners including MD Anderson Cancer Center, St. Jude Children’s Research Hospital, AstraZeneca, Pfizer and MSD.

Partner support for UICC’s Lung Cancer Collaboration continued to grow with partners Boehringer Ingelheim, AstraZeneca, Pfizer and MSD joining in 2025.

New partners Novo Nordisk Fonden and Menarini Stemline supported UICC’s work in Antimicrobial Resistance (AMR) including a focus on incorporating AMR in National Cancer Control Plans (NCCPs).

“At Bristol Myers Squibb, we believe that sustainable healthcare systems depend on the ability to translate innovative science into meaningful, real-world outcomes for patients – especially those facing the greatest barriers to care. Achieving this requires collaborative approaches across sectors to strengthen health system resilience, improve access to care and ensure that biomedical advances deliver value for patients, communities and society.”

Martin Whalen, SVP, Global Policy & Government Affairs, BMS

“At Roche we recognise that no one organisation, company, country, intervention or individual can deliver this alone. That’s why we see partnerships with governments, public health authorities, advocacy networks, civil society and other stakeholders as vital to addressing current barriers to cancer care access and innovation.”

Michael Oberreiter, Head Global Access, Roche

“The 2025 UN High-Level Meeting on NCDs marked a pivotal moment for the global cancer agenda. World Cancer Research Fund International was proud to work alongside UICC and its partners to translate the moment into meaningful commitments to reduce cancer rates worldwide. Our collaboration with UICC in global advocacy, scientific initiatives such as the Reimagining Cancer Research in Europe Initiative, and knowledge exchange demonstrate what is possible when organisations align their expertise and advocacy towards shared goals. We look forward to continuing to build on our collective progress in the years ahead.”

Dr Panagiota Mitrou,

Executive Director of Research and Policy, World Cancer Research Fund International

Susan G Komen • Princess Margaret Cancer Centre

Knowledge generation and sharing

Reimagining Cancer Research in Europe initiative

This regional initiative, launched in 2022, and conceptualised and supported by UICC member organisations in Europe, received commitments of a further EUR 800,000 in 2025, enabling the launch of a second call for applications. The funding represents renewed commitments from two existing partners of the initiative, the Swedish and Danish cancer societies, as well as investments from new partners, World Cancer Research Fund (WCRF) International and Wereld Kanker Onderzoek Fonds (WKOF).

A total of EUR 1.3 million will be available to be awarded through the second call, which opened in November 2025 and will close on 16 February 2026. Groups of collaborating applicants will be able to apply for grants of a maximum of EUR 500,000. The initiative aims to support collaborative implementation research projects and further leverage the potential of cancer prevention to reduce the burden of cancer in Europe.

Uppsala University / Swedish Cancer Society

Cancer Systems and Control for Health Professionals

In March, UICC announced the publication of Cancer Systems and Control for Health Professionals, edited by Meredith Giuliani, Mary Gospodarowicz, James Brierley, and Richard Sullivan. Published by Wiley, this landmark resource addresses the global challenge of cancer by advocating for a systems-based approach to its complexities. The book integrates perspectives from medicine, education, technology, public health, health policy, and advocacy, underscoring the importance of a comprehensive ecosystem in cancer care. It explores social determinants of health, health economics, and strategies for cancer control, while highlighting structural barriers to health equity. Furthermore, it examines the role of data management and emerging technologies such as artificial intelligence and quantum computing in advancing cancer control. Designed for clinicians and researchers, this resource will serve UICC members and the broader cancer community.

TNM Classification of Malignant Tumours, 9th edition

July saw the launch of the TNM 9th edition edited by Drs James Brierley, Meredith Giuliani, Brian O’Sullivan, Brian Rous, and Liesbet Van Eycken. This edition introduces revised criteria and new classifications, reflecting advances in imaging, tumour biology, and patient care. It provides internationally agreed standards to support more accurate and personalised cancer treatment worldwide. In 2026, it will mark 58 years since its first publication by UICC.

International Journal of Cancer

The International Journal of Cancer published several special issues to coincide with milestone awareness days including World Cancer Day and Breast Cancer Awareness month. In 2025, IJC published 260 Open Access Articles, which is up 6% from 246 articles in 2024. The most highly read paper in 2025 was The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide, with 21,960 views. Since 2023, IJC has published articles from World Cancer Research Fund International’s Global Cancer Update Programme which analyses global research on how diet, nutrition and physical activity affect cancer risk and survival. A paper on Early-life anthropometry and colorectal cancer risk in adulthood was published in May. In 2026, the IJC will mark 60 years since the publication of its very first issue on 15 January 1966.

Sister organisations

UICC is proud to have been involved in the establishment of the NCD Alliance, the McCabe Centre for Law and Cancer, the International Cancer Control Partnership and the City Cancer Challenge Foundation. We applaud the achievements and impact each organisation has had in 2025 and encourage you to learn more on their websites.

ncdalliance.org

mccabecentre.org

iccp-portal.org

citycancerchallenge.org

UICC members around the world

“It has been a great pleasure to serve as Treasurer of UICC in 2025. I am proud to be part of an organisation that demonstrates professionalism, transparency, and strong financial management in the way it conducts its work and manages its resources.”

Gonzalo Lopez Cuevas, Treasurer, UICC

In 2025, UICC concluded the year with a balanced budget, posting a small operational loss of CHF 38,000. These financial results were achieved with an increase in staffing from 44 to 47 FTE during the year. The financial stability, and the financial reserve position remained at a healthy level. In addition, UICC received a clean audit from PricewaterhouseCoopers (PwC).

It is worth considering UICC’s financial performance in the context of funding challenges experienced across international organisations and NGOs in Geneva in 2025. UICC is fortunate that the geopolitical issues affecting financial support to many Geneva organisations have not impacted it to date.

Balance sheet at 31 December in Swiss francs (CHF)

ASSETS

These figures, as presented, represent a summary of the financial statements of UICC. A complete set of the audited financial statements for 2025, including accompanying notes, may be obtained upon request at finance@uicc.org.

LIABILITIES

Income and expenditure at

31

December in Swiss francs (CHF)

INCOME

Membership Dues & Contributions

Partnerships 1,484,038 1,484,038

Improving member centricity 944,902 944,902

Improving access 1,418,628 1,418,628

Improving health systems for cancer 1,288,088 1,288,088

Advocating for greater people-centred care 580,386 580,386

Increasing attention on women's cancer 1,106,509 1,106,509

Increasing attention on lung cancer

World Cancer Leaders' Summit 1,147,682 1,147,682

World Cancer Congress 637,785 637,785

Other initiatives 736,666 736,666

Publications

Others

TOTAL INCOME

EXPENDITURE

Improving member centricity

(1,604,244) (1,604,244)

Improving access (2,178,009) (2,178,009)

Improving health systems for cancer (1,046,848) (1,046,848)

Advocating for greater people-centred care (583,077) (583,077)

Increasing attention on women's cancer (345,142) (345,142)

Increasing attention on lung cancer (623,261) (623,261)

World Cancer Leaders' Summit (1,311,899) (1,311,899)

World Cancer Congress (279,288) (279,288)

Other initiatives (612,791) (612,791)

Publications (261,792) (261,792)

Others (182,010) (182,010)

Operating Costs (4,078,666) (4,078,666)

TOTAL

These figures, as presented, represent a summary of the financial statements of UICC. A complete set of the audited financial statements for 2025, including accompanying notes, may be obtained upon request at finance@uicc.org

Result before allocation to the fund capital

Allocation of the

Allocation

(475,348) (513,567)

(613,373) (19,821) (19,821) (2,959,079) (2,959,079) (503,932) (503,932) (589,914) (589,914) (91,882) (91,882)

Our Board and team

Past and current members of the UICC Board of Directors at the World Cancer Leaders’ Summit in Melbourne.

The 2024–2026

Board of Directors

President

Ulrika Årehed Kågström

Sweden

Following its election by the UICC General Assembly in October 2024, the Board of Directors for the 2024–2026 term continued its work throughout 2025. The Board governs UICC in line with the mandate received from the General Assembly and provides leadership and strategic direction across all UICC activities. Comprising 16 outstanding and dedicated individuals, it is chaired by the incumbent President and includes the President-elect.

President-elect

Zainab Shinkafi-Bagudu

Nigeria

Matti Aapro Switzerland

Stella Aguinaga Bialous United States of America

Eric Bouffet Canada

Gonzalo Lopez Cuevas Mexico

Maira Caleffi Brazil

Hana Chaar Choueib Lebanon

Todd Harper Australia

Asem Mansour Jordan

Christopher Jackson New Zealand

David Kerr United Kingdom

Gilberto Lopes United States of America

Miriam Mutebi Kenya

C S Pramesh India

Kathleen Schmeler United States of America

UICC team members who attended the World Cancer Leaders’ Summit in Melbourne.

UICC team

The list includes all staff who worked at any point in time between 1 January and 31 December 2025.

Photography by

Adrien Buttier

Edis Potori

Leigh Mullens

Ramiro Sanchez

Gilberto Lontro

Chief Executive Officer

Cary Adams

Chief Operating Officer

Philippe Guinot

Capacity Building

Kirstie Graham

Alessandro Di Capua

Annah Espejo

Caroline Gloor

Esther Peev

Marta Pazos Belart

Nisso Käser

Rosanne Lamplough

Sabrina Zucchello

Sally Donaldson

Serena Forni

Victoria Paget

Communications & Marketing

Nicole Engelbrecht

Alexandra La Guardia

Amy Kirby-Okello

Charles Revkin

Eric Grant

Giovanna Giuga

Nina Caleffi Scaletscky

Rabab Ouardighi

Shadia Kuoni

Congress & Events

Céline Francina

Anaïs Armengaud

John Lawlor

Ronan Carella

Yani Amar

Finance & Administration

Philippe Guinot

Mondine Moeschler

Cindy Ray

Eszter Klampfer

Guillaume Roth

Minh Nguyen

Viran Silva

Knowledge, Advocacy & Policy

Sonali Johnson

Emily Joynes

Rosie Tasker

Shalini Jayasekar-Zurn

Yannick Romero

Zuzanna Tittenbrun

Memberships

Muriel Victoria Auclaire

Adrian Bourquin

Laila Harras-Pelletier

Laura Fernandez Diaz

Shirine Ajil

Partnerships

Sophie Matte

Bijoya Banerjea

Gwenn Brézillon

Jessica Clerc

Karine Belondrade

Lua Nazerian

Maarten De Winter

Maribeth Walker

ATOM Coalition

Dan Milner

Natasha Shah

Amy Israel

Anna Cabanes

Kah Shin Cheong-Baden

Megan Young

Melissa Rendler-Garcia

Sarbani Chakraborty

Sumi Krishnamurthy

Ruth Njengere Lehmann

Our members

UICC members around the world

UICC would like to thank the organisations highlighted in blue that kindly made voluntary contributions above and beyond their statutory membership to support members through the Membership Support Fund.

AFGHANISTAN

Afghanistan NCD Alliance

ALGERIA

Association d’Aide aux Enfants

Cancéreux - Béchar

Association des Médecins Libéraux d’Annaba

Association El-Amel d’aide aux personnes atteintes de cancer, Centre Pierre et Marie Curie (CPMC)

Chu Annaba - Clinique Médicale Infantile Sainte

El Adwa

EL BADR

Errahma

Nassima

Nour Doha

Sociéte Algerienne de Formation et de Recherche en Oncologie (SAFRO)

Waha

ANGOLA

Instituto Angolano de Controlo do Cancer (IACC)

ANGUILLA

Anguilla Family Planning Association

ANTIGUA AND BARBUDA

Antigua Planned Parenthood Association

Caribbean Family Planning Affiliation, Ltd.

ARGENTINA

Asociación Leucemia Mieloide de Argentina (ALMA)

Donde Quiero Estar Foundation

Fundación para la Salud del Adolescente

Fundación SALES

Liga Argentina de Lucha Contra el Cáncer (LALCEC)

Linfomas Argentina

Sociedad Latinoamericana y del Caribe de Oncología Médica (SLACOM)

ARMENIA

City of Smile Charitable Foundation

CML Armenia

Immune Oncology Research Institute

ARUBA

Foundation for Promotion of Responsible Parenthood

AUSTRALIA

Adelaide Hills PCSG

Adelaide Mitcham PCSG

Albany PCSG

Albury Wodonga PCSG

Alice Springs PCSG

Anastasia Greek Cancer Support Group

Ararat & District Prostate Cancer Support Group

Armidale PCSG

Australian Catholic University

Australian Catholic University, Exercise Lifestyle Clinic

Australian Centre for the Prevention of Cervical Cancer (ACPCC)

Bairnsdale Prostate & Partners Support Group

Ballarat Prostate Cancer Support Group

Barossa Prostate Cancer Support Group

Bass Coast Prostate Cancer Support Group

Bathurst Prostate Cancer Support Group

Bayside Kingston PCSG

Bendigo & Districts Prostate Cancer Support Group

Biloela PCSG

Blackwood Districts PCSG

Bowel Cancer Australia

Box Hill PCSG

Breast Cancer Network Australia

Brisbane Prostate Cancer Support Network

Broken Hill Prostate Cancer Support Group

Bunbury District Prostate Cancer Support Group

Bundaberg & District Prostate Cancer Support Group

Busselton PCA&SG

Cancer Australia

Cancer Council ACT

Cancer Council Australia

Cancer Council Northern Territory

Cancer Council NSW

Cancer Council Queensland

Cancer Council South Australia

Cancer Council Tasmania

Cancer Council Victoria

Cancer Council Western Australia

Cancer Institute NSW

Cancer Nurses Society of Australia

Central Australia Support Group

Leaders Teleconference Group

Central Coast Carers Group

Central Coast PCSG

Central Coast Pre Op Support Group

Central Gold Coast PCSG

Cessnock Prostate Cancer Support Group

Chinese Cancer Society of Victoria Cancer Support Group

Citiplace Advanced PCSG

Clarence Valley Prostate Cancer Support Group

Clayton Greek Cancer Support Group

Coffs Harbour PCSG

Collaborate against CancerMinderoo Foundation

Collie PCSG

Concord PCSG

Cootamundra PCSG

Darwin Prostate Support Awareness Group - Prosper

Denmark PCSG

Devonport PCSG

Diamond Valley PCSG

Dubbo PCSG

Dural PCSG

Eastern Shore PCSG

Essendon PCSG & Diamond Valley PCSG

Far North Queensland (Cairns) PCSG

Far North Queensland PCSG

Forbes Prostate Cancer Support Group

Frankston & District PCSG

Fremantle PCSG

Gawler PCSG

Gay Melbourne Prostate Cancer Group

Gay Prostate Support Adelaide

Gay/Bisexual Prostate Cancer Support

QLD

Geelong Prostate Support Group

Glass House Country PCSG

Glen Innes PCSG

Gold Coast North Prostate Cancer Support & Awareness Group

Gold Coast Prostate Cancer Partners Support Group

Goulburn & District Prostate Cancer Support Group

Granite Belt PCSG

Great Lakes Prostate Cancer Support Group

Griffith PCSG

Gympie & District PCSG

Hastings Prostate Cancer Support Network

Hervey Bay Prostate Cancer Support Group

Illawarra Prostate Cancer Support Group

Innisfail Prostate Support Group

Inverell PCSG

Ipswich Prostate Cancer Support Group

Kalamunda PCSG

Kingborough PCSG

Kingston & Robe PCSG

Kyabram & District Prostate Support Group

Latrobe Valley Prostate Support Group

Leederville Prostate Exercise Group

Leukaemia Foundation of Australia

Limestone Coast PCSG

Lockyer Valley PCSG

Lower Eyre Prostate Cancer Support Network

Lower North PCSG

Lymphoma Australia

Mackay & District Prostate Cancer Support Group

Mandurah PCSG

Maryborough Prostate Cancer Support Group

Melmarsh Prostate Cancer Support Group

Mens Engagement Network

Monaro Prostate Cancer Support Group

Monash University

Monash University Prostate Cancer Research Group

Mudgee Prostate Cancer Support Group

Murray Bridge PCSG

Naracoorte Mens Cancer Support Group

National Breast Cancer Foundation

Nepean/Blue Mountains PCSG Inc.

Newcastle/Hunter Mater Prostate Cancer Support Group

North Burnett PCSG

North Shore PCSG

North West QLD Prostate Cancer Support Group

Northern Beaches Prostate Cancer Support Group

Northern Rivers Day PCSG

Northern Rivers Evening PCSG

Northern Tablelands PCSG

Northern Territory Rainbow PCSG

Ocean Reef PCSG

Orange PCSG

Orbost PCSG

Parkes Prostate Awareness and Support Group

PCS - City of Onkaparinga Group

PCSG Bellarine Peninsula

Peninsula Prostate Cancer Support Group Inc.

Perth Gay/Bisexual PCSG

Perth Partners Group

Perth PCSG

Perth Southsiders Prostate Cancer Support Group

Perth Western Suburbs Group

Peter MacCallum Cancer Centre

Port Pirie PCSG

Prostamates Support Group

Prostate (Cancer) Support Awareness

Adelaide Group

Prostate Awareness Twin Town & Tweed Coast

Prostate Cancer Action Group (S.A.) Inc.

Prostate Cancer Foundation of Australia

Prostate Cancer Partners SG Bentleigh Bayside

Prostate Cancer Support Group ACT Region

Prostate Cancer Support Group of Younger Men

Prostate Heidelberg

Prostate Melbourne Support Group

Prostate Support Group Warrnambool

QLD Advanced PCSG (Telephone Group)

Queensland and Northern

NSW Support Group Leaders Teleconference Group

Rare Cancers Australia

Redcliffe PCSG

Ringwood PCSG

Riverland PCSG

Rockhampton PCS&A Group

Royal Prince Alfred Hospital PCSG (Day Group)

Royal Prince Alfred Hospital PCSG (Evening Group)

Saddleworth PCSG

Shepparton & District PCSG

Shine A Light Group for Gay/Bisexual Men

Shoalhaven PCSG

South Perth PCSG

Southern Highlands PCSG

St Arnaud PCSG

St Vincents PCSG

St Vincent’s PCSG for Women

Stay Strong Prostate Cancer Exercise Group

Sunraysia Prostate Support Group

Sunshine Coast PCSG

Swan Hill Prostate Support Group

Sydney Adventist Hospital Educational Presentations (Night)

Sydney Adventist Hospital Facilitated Group Discussion (Day)

Tamworth Prostate Cancer Support Group

Taree PCSG

Tatiara Prostate Cancer Support Group

Tomaree PCSG

Toowoomba Prostate Cancer Support Group

Townsville PCSG

University of Southern Queensland VCCC Alliance

Victoria and Tasmania Support Group Leaders Teleconference Group Wagga Wagga PCSG

Walter & Eliza Hall Institute of Medical Research

Western Australia Support Group Leaders Teleconference Group

Westgate Region Prostate Cancer Support Group

Westmead PCSG

Westside Prostate Cancer Support Group

Whyalla PCSG

Wimmera Prostate Cancer Support Group

Wyong PCSG

Yorke Peninsula PCSG

Younger Men Central Coast PCSG

Younger Men PCSG - Leederville

Younger Men’s Prostate Cancer Teleconference Group

BAHAMAS

Bahamas Family Planning Association

BAHRAIN

London breast care centre

BANGLADESH

Bangladesh Cancer Society

Bangladesh Society for Breast Cancer Study (BSBCS)

Community Oncology Centre Trust

Oncology Club, Bangladesh

BARBADOS

Barbados Family Planning Association

The Myeloma, Lymphoma and Leukaemia Foundation of Barbados

BELGIUM

All.Can International

Belgian Foundation against Cancer

European Cancer Organisation

European Organisation for Research and Treatment of Cancer (EORTC)

European Society for Radiotherapy & Oncology (ESTRO) - VAT n° BE0432.894.370

HPV Prevention and Control Board

Kom op tegen Kanker

Lymfklierkanker Vereniging Vlaanderen vzw

The Synergist - From Testing to Targeted Treatment Program (FT3)

World Bladder Cancer Patient Coalition

BELIZE

Belize Family Life Association

BENIN

Association Franco Béninoise de Lutte Contre le Cancer

Association pour la Lutte Contre le Cancer au Bénin

Fondation Claudine Talon

Pink Bénin

SOS Cancer

BERMUDA

Bermuda Cancer and Health Centre Teen Services

BHUTAN

Bhutan Cancer Society

BOLIVIA PLURINATIONAL STATE OF

Centro de Investigación, Educación y Servicios (CIES)

Fundación Boliviana Contra el Cáncer

BOSNIA-HERZEGOVINA

Potencijal Una Sana

BOTSWANA

Cancer Association of Botswana

Nurses Association of Botswana

BRAZIL

ABRALE Brazilian Lymphoma and Leukaemia Association

Américas Amigas

Amigos na Luta Contra o Câncer

Associação Amor a Vida

Associação Brasileira de Apoio aos Pacientes de Câncer (ABRAPAC)

Associação Brasileira de Portadores de Câncer AMUCC

Associação Brasiliense de Apoio ao Paciente com Câncer - ABAC-Luz

Associação Capanemense de Apoio e Prevenção ao Câncer da MulherAPCM

Associação Cascavel Rosa

Associação Cearense das Mastectomizadas - Toque de Vida

Associação das Amigas da MamaAAMA

Associação das Mulheres Iguatuenses

Associação de Apoio a Mulher

Portadora de Neoplasia - AAMN

Associação de Apoio de pessoas com Câncer

Associação de Combate ao Câncer da Grande Dourados - ACCGD

Associação de Combate ao Câncer do Brasil Central - ACCBC

Associação de Mulheres Atuantes de Paraíso do Tocantins - AMAP

Associação de Mulheres

Mastectomizadas de Brasília

Associação do Câncer Amor PróprioUma Luta pela Vida - AMOR PRÓPRIO

Associação dos Amigos da Mama de Niterói (ADAMA)

Associação dos Amigos da Oncologia (AMO)

Associação dos Amigos de Prevenção do Câncer- GAMA

Associação dos Amigos do CRIOASSOCRIO

Associação em Educação e Saúde da Mama Jesuína Estrela (AMAJES)

Associação Feminina de Educação e Combate ao Câncer - AFECC

Associacao Hospitalar Moinhos de Vento

Associação Laço Rosa - pela cura do câncer de mama - Fundação Laço

Rosa

Associaçao Limeirense de Combate ao Câncer (ALICC)

Associação Petropolitana de Pacientes Oncológicos - APPO

Associação Rosa Viva - ROSAVIVA

Bem-Estar Familiar no Brasil (BEMFAM)

Brazilian Oncology Nursing Society

Brazilian Society of Surgical Oncology

Centro de Integração Amigas da Mama- CIAM

Elas Por Elas Vozes e Ações das Mulheres

Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama (FEMAMA)

Fundação Antonio Prudente - A.C. Camargo Cancer Center

Fundação do Câncer, Brazil

Fundação Maria Carvalho SantosFMCS

Grupo Beltronense de Prevenção ao Câncer

Grupo de Mama Renascer - GRUMARE

Grupo para Motivação e Auto-Ajuda

Renovadora - Grupo AMAR

Grupo Rosa e Amor

Hospital de Base

Hospital de Caridade de Ijui

INCA Instituto Nacional de Câncer

Instituto Avon

Instituto da Mama do Rio Grande do Sul - IMAMA

Instituto de Desenvolvimento e Valorização Humana

Instituto Desiderata

Instituto do Câncer do Ceará - ICC

Instituto Humanista de Desenvolvimento Social - HUMSOL

Instituto Oncoguia

Liga Mossoroense de Estudos e Combate ao Câncer - Grupo Toque de Mama

Liga Norteriograndense Contra o Câncer - Grupo Despertar

Núcleo Assistencial para Pessoas com Câncer - NASPEC

Rede Feminina de Combate ao Câncer de Blumenau - RFCC

Rede Feminina de Combate ao Câncer de Brasília (RFCC- DF)

Rede Feminina de Combate ao Câncer de Brusque - RFCC

Rede Feminina de Combate ao Câncer de Gaspar

Rede Feminina de Combate ao Câncer de Itajaí - RFCC

Rede Feminina de Combate ao Câncer de Jaraguá do Sul - RFCC - JS

Rede Feminina de Combate ao Câncer de Maravilha - R.F.C.C.-Maravilha

Rede Feminina de Combate ao Câncer de Ponta Porã - RFCCPP

Rede Feminina de Combate ao Câncer de São Bento do Sul

Rede Feminina de Combate ao Câncer de União da Vitória- RFCC - UV

Rede Feminina de Combate ao Câncer de Xaxim

Rede Feminina de Combate ao Câncer do Amazonas

Rede Feminina de Combate ao Câncer em Alagoas - RFCC

Rede Feminina Regional de Combate ao Câncer de Xanxerê - R.F.C.C.Santa Catarina

Saude Alegria E Sustentabilidade Brasil

União e Apoio no Combate ao Câncer de Mama - UNACCAM

BRUNEI DARUSSALAM

Pantai Jerudong Specialist Centre

BULGARIA

Bulgarian Cancer Scientific Society

Bulgarian Lymphoma Patients’ Association

Bulgarian Oncology Nursing Society

BURKINA FASO

Action Contre le Cancer Infantile au Burkina Faso

Coalition Burkinabè Contre le Cancer (COBUCAN)

Espoir Cancer Féminin

Foundation Kimi

Groupe d’action contre le cancer

Solidarité contre le cancer

BURUNDI

Kenyera Non-Governmental Organization

CAMBODIA

Calmette Hospital

Douleurs Sans Frontières

Sihanouk Hospital Center of HOPE

CAMEROON

Association des Volontaires pour la Santé Familiale

Cameroon Baptist Convention Health Services (CBCHS)

Cameroon Laboratory & Medicine

Foundation Health Centre

Humanity at Heart International Association (H@H)

Reconciliation and Development Association

RSD Institute

Solidarité Chimiothérapie - SOCHIMIO

CANADA

Canadian Association of Nurses in Oncology

Canadian Association of Provincial Cancer Agencies

Canadian Association of Radiation Oncology (CARO - ACRO)

Canadian Cancer Society

Canadian Federation for Sexual Health

Canadian Partnership Against Cancer (CPAC)

CancerCare Manitoba

Centre Hospitalier de l’Université de Montréal

Department of Oncology, Faculty of Medicine, McGill University

International Psycho-Oncology Society (IPOS)

International Society of Nurses in Cancer Care (ISNCC)

Lymphoma Canada

Lymphoma Coalition

Melanoma Canada

Ontario Health

Ontario Institute for Cancer Research

Pancreatic Cancer North America (PCNA)

Princess Margaret Cancer Centre

Rethink Breast Cancer

World Ovarian Cancer Coalition

CHAD

Association DONAMA

Association Tchadienne Contre le Cancer

Association Tchadienne des Femmes Vivants avec le Cancer

CHILE

Asociación Chilena de Protección de la Familia

Corporación Nacional Maxi-Vida

Fundación Arturo López Pérez

Fundacion Chile sin cancer

Fundación Foro Nacional de Cáncer

Instituto del Cáncer Redsalud (razón social Oncomercial y Oncosalud)

CHINA

Beijing Cancer Hospital

China Anti-Cancer Association (CACA)

Chinese Medical Association

Fudan University Shanghai Cancer Center

Guangzhou Concord Cancer Center (GCCC)

HOUSE086

Jiangxi Cancer Hospital

Liaoning Cancer Hospital & Institute

New Sunshine Charity Foundation

Oncology Nursing Committee of Chinese Nursing Associations

Sun Yat-sen University Cancer Center

Tianjin Anti-Cancer Association, China

Tianjin Medical University Cancer Institute & Hospital

COLOMBIA

Asociación Pro-Bienestar de la Familia

Colombiana

Fundación Colombiana de Leucemia y Linfoma

Fundación Ellen Riegner de Casas

Fundación Salamanca Borrero SalBo

Instituto Nacional de CancerologíaColombia

La Asociacion de Enfermeria

Oncologica Colombiana

Liga Colombiana Contra el Cáncer

COMOROS

Union Comorienne Contre le Cancer

CONGO (BRAZZAVILLE)

Accompagnez la vie

Association des Infirmiers du Congo

Bénévoles pour le Bien être Familial

Fondation Calissa Ikama

Fondation Globeathon Congo Brazzaville

CONGO DEMOCRATIC REPUBLIC (KINSHASA)

Agir Ensemble

Congo Cancer Foundation

La Ligue Africaine pour la Lutte contre le cancer du sein (LALuCaS)

Ligue Congolaise Contre le Cancer

Palliafamilli

SOCAP

COSTA RICA

Asociación Demográfica

Costarricense

Asociacion Metamorfosis

Asociación nacional venciendo los obstáculos de la vida (ANASOVI)

Asociacion Profesional del Enfermeras

Oncohematologicas

Destrezas para la Salud

Foro Permanente de Cáncer en Mujeres de Costa Rica

Unidos contra el Cáncer

CÔTE D’IVOIRE

Aidons les Personnes Atteintes ou Affectées par le Cancer

Association de Soins Palliatifs de Côte d’Ivoire

Association Imagine le Monde

Association Ivoirienne de Lutte Contre le Cancer

Centre National d’Oncologie Médicale et de Radiothérapie Alassane OUATTARA (CNRAO)

Coalition des Organisations de Lutte contre le Cancer en Côte d’Ivoire (COLCC-CI)

Hope Life

Ligue Ivoirienne Contre le Cancer

Programme National de Lutte contre le cancer (PNLCa)

CROATIA

Croatian League Against Cancer

Hrvatska udruga leukemija i limfomi (HULL) (Croatian Leukemia & Lymphoma Society)

Udruga Oboljelih od leukemije I limphoma (UOLL)/ Association of patients with leukemia and lymphoma

CUBA

Sección Independiente de Control del Cáncer

Sociedad Científica Cubana para el Desarrollo de la Familia

CURAÇAO

Foundation for the Promotion of Responsible Parenthood

CYPRUS

Cyprus Anti-Cancer Society

Cyprus Association of Cancer Patients & Friends

CZECH REPUBLIC

Hlas onkologických pacientů (HOP, Cancer Patients Voice)

League Against Cancer Prague Lymfom Help

DENMARK

Danish Cancer Society

SMILfonden

DJIBOUTI

Association pour le Développement du Millénaire

DOMINICA

Dominica Cancer Society

Dominica Planned Parenthood Association

DOMINICAN REPUBLIC

Asociación Dominicana Pro-Bienestar de la Familia

Liga Dominicana Contra el Cáncer

Patronato Cibaeño Contra el Cáncer

Un Paso Max

ECUADOR

Asociación Ecuatoriana de Ayuda a Pacientes con cáncer “Esperanza y Vida”

Centro Ecuatoriano para la Promoción y Acción de la Mujer

Hospital SOLCA Quito

EGYPT

Arab Medical Association Against Cancer (AMAAC)

Association d’aide aux Malades du Cancer dans l’Oasis de Dakhla

Association Médicale FrancoEgyptienne

Baheya Foundation for Early Detection & Treatment of Breast Cancer

Breast and Gynecological International Cancer Society (BGICS)

Can Survive Egypt Cancer Care Egypt

Egyptian Cancer Society

Egyptian Society for Promotion Of Women’s Health

National Cancer Institute - Cairo

Shefaa El Orman Oncology Hospital (SOH)

We Want Life

EL SALVADOR

Asociación Demográfica Salvadoreña

Asociación Salvadoreña para la Prevención del Cáncer

Fundación Edificando Vidas, El Salvador

ESTONIA

Estonian Cancer Society

ETHIOPIA

Addis Ababa University

Ethiopian Cancer Association

Mathiwos Wondu Ye-Ethiopia Cancer Society

FIJI

Fiji Cancer Society

Fiji Islands Ministry of Health and Medical Services

FINLAND

Cancer Society of Finland

Suomen Syöpäpotilaat - Cancer patienterna Finland (Association of Cancer Patients in Finland)

FRANCE

AFROCANCER

Alliance Mondiale Contre le Cancer

Association Française des Infirmiers de cancérologie

Cancer Support France

Cancérologues Sans Frontières

Centre Antoine Lacassagne

Centre Eugène Marquis

Centre François Baclesse

Centre Georges-François Leclerc

Centre Henri Becquerel

Centre Jean Perrin

Centre Léon Bérard

Centre Oscar Lambret

Contre-Feu, l’alliance contre l’industrie du tabac

ELLYE

Expertise France

Fondation ARC pour la Recherche sur le Cancer

French League Against Cancer

Groupe Franco-Africain d’Oncologie Pédiatrique

Gustave Roussy

Gynécologie Sans Frontières

Institut Bergonié

Institut Claudius Regaud - IUCT

Oncopole

Institut Curie

Institut de Cancérologie de Lorraine

Institut de Cancérologie de l’Ouest

Institut de cancérologie Strasbourg Europe (ICANS)

Institut du Cancer de Montpellier

Institut Godinot

Institut National du Cancer (INCA)

Institut Paoli Calmettes

Institut pour la Prévention de Cancer du Sein

L’Association de Soutien et d’Information à la Leucémie

Lymphoïde Chronique et la maladie de Waldenström (SILLC)

Médecins du Monde France

Médecins Sans Frontières (MSF)

NESSMA

OncoMali

Pathologie Cythologie et Développement

Patients en réseau

Physicien Médical Sans Frontières

Raid Evasion Run

SOS Don de Moelle Osseuse Moyen Orient

UNICANCER

UNICANCER Institut du cancer de Polynésie française - Tahiarua Onohi Mihinoa a Tati, dit “Tiurai”

UNICANCER Saint-Catherine - Institut du Cancer d’Avignon-Provence

GABON

Fondation Sylvia Bongo Ondimba (FSBO)

Ligue Gabonaise Contre le Cancer

GAMBIA

Network of AIDS Services Organization (NASO)

GEORGIA

Georgian Nursing Association

Research Institute of Clinical Medicine (Todua Clinic)

The Alliance of Chronic Myeloid Leukemia Patients of Georgia

GERMANY

Deutsche Krebsgesellschaft e.v. - DKG

Deutsche Leukaemie & Lymphom -Hilfe eV

Deutsches Krebsforschungszentrum (DKFZ)

European Society Of Oncology Pharmacy - ESOP Global

Initiative krebskranke Kinder München e.V.

Leukaemiehilfe RHEIN-MAIN e.V. (LHRM)

GHANA

African Cancer Organisation

Breast Care International (BCI)

Embrace Society

Lifeline for Childhood Cancer Ghana Mctonne Cancer Care Foundation

GREECE

CLL Greece (Hellenic Group of Patients with CLL)

Hellenic Association of Women with Breast Cancer, “Alma Zois”

Hellenic Cancer Federation - ELLOK

International Institute of Anticancer Research

GRENADA

Grenada Planned Parenthood Association

GUADELOUPE

Association Guadeloupeenne pour le Planning Familial

GUATEMALA

Asociación de Pacientes con LMC -ASOPALEU-

Asociación Guatemalteca Héroes de Esperanza

Instancia por la salud y el desarrollo de las Mujeres ISDM

Liga Nacional Contra el Cáncer Guatemala

One Voice Against Cancer

GUINEA

Association Guinéenne pour la Lutte contre le Cancer

Génération Sans Tabac

Programme national de lutte contre le cancer (PNLCC) - Guinée

GUYANA

Guyana Cancer Prevention Society

Guyana Responsible Parenthood Association

HAITI

Association pour la Promotion de la Famille Haitienne

HONDURAS

Asociación de Pacientes con Cáncer Fe Y Esperanza

Asociación Hondureña de Lucha contra el Cáncer

Asociación Hondureña de Planificación de Familia

Fundación Hondureña para el Niño con Cáncer

Liga Contra el Cáncer - Honduras

HONG KONG

Asian Fund for Cancer Research

Cancer Patient Alliance

Cancerinformation.com.hk Charity Foundation Limited

Global Chinese Breast Cancer Organizations Alliance

Hong Kong Anti-Cancer Society

Hong Kong Blood Cancer Foundation (HKBCF)

Maggie Keswick Jencks Cancer Caring Centre Foundation Ltd.

HUNGARY

Hungarian League Against Cancer

Magyar Onkohematológiai Betegekért Alapítvány (MOHA)

Magyar Rákellenes Liga

INDIA

Alamelu Charitable Foundation (Supported by Tata Trusts)

All India Institute of Medical Sciences, Guwahati

Apollo Cancer Institute, Apollo Hospitals - Hyderabad

Association Of Medical and Pediatric Oncologists of Kerala (AMPOK)

Basavatarakam Indo American Cancer Hospital & Research Institute

CanCare Foundation

Cancer Institute WIA

Cancer Patients Aid Association

Cancer Society of Madhya Pradesh

CanKids...KidsCan

Dharamshila Narayana Superspeciality Hospital

Dr. Bhubaneswar Borooah Cancer Institute

Friends of Max HCG Hospital

Indian Cancer Society - National HQ

Indian Society of Oncology

Konaseema Institute of Medical Sciences and Research Foundation (KIMS)

Lung Connect India Foundation

Mahatma Gandhi Cancer Hospital & Research Institute

Malabar Cancer Centre

Manage Health Foundation

Manipal Comprehensive Cancer Care Centre, Kasturba Medical College, Manipal, Manipal Academy of Higher Education (MCCCC)

Netaji Subhas Chandra Bose Cancer Hospital

No Tobacco Association

Oncology Forum

PSG Institute of Oncology

Rajiv Gandhi Cancer Institute & Research Centre

Rajkot Cancer Society

Regional Cancer Centre, Thiruvananthapuram, Kerala, India

Saroj Gupta Cancer Centre & Research Institute

Tata Memorial Hospital

The Federation of Asian Organizations for Radiation Oncology (FARO)

The Gujarat Cancer & Research Institute

The Oncology Nurses Association of India

Tibetan Cancer Society V Care Foundation

Vedanta Medical Research Foundation, Balco Medical Centre

INDONESIA

Faculty of Medicine Universitas Indonesia

Indonesia CML & GIST Community, ELGEKA

Indonesian Breast Cancer Foundation / Yayasan Kanker Payudara Indonesia

Indonesian Cancer Foundation

Indonesian Cancer Information and Support Center Association (CISC)

Indonesian Oncology Nurses Association

Indonesian Radiation Oncology Society (IROS)

Makassar Cancer Care Community (MC3)

Rumah Sakit Kanker DharmaisNational Cancer Center

IRAN, ISLAMIC REPUBLIC OF Behnam Daheshpour Charity Organization

Cancer Institute, Imam Khomeini Medical Center

MAHAK “Society to Support Children Suffering from Cancer”

Reza Radiotherapy and Oncology Center

IRAQ

Bring Hope Humanitarian Foundation

Nab’a Al-Hayat Foundation for Medical Sciences and Health Care

Rizgary Oncology Center

Warith Foundation for Public Health (WFPH)

Zhianawa Cancer Center

IRELAND

Aoibheann’s Pink Tie CLL Ireland

Irish Cancer Society

Lymphoma Support Ireland

National Cancer Control Programme

ISRAEL

Hadassah

Israel Cancer Association

The Flute of Light

ITALY

Associazione Italiana contro le Leucemie-linfomi e mieloma – Pazienti (AIL)

Associazione Italiana di Oncologia Medica (AIOM)

Associazione Tumori Toracici Rari, TUTOR

Centro di Riferimento per l’Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO)

EUROPA DONNA - The European Breast Cancer Coalition

European School of Oncology

Fondazione “Edo Ed Elvo Tempia Valenta” Onlus

Fondazione AIRC per la ricerca sul cancro

Fondazione IRCCS “Istituto Nazionale dei Tumori”

Gruppo Abruzzese Linfomi (GAL)

Linfovita

Soleterre ETS Foundation

WALCE Onlus

JAMAICA

Jamaica Family Planning Association

JAPAN

Aichi Cancer Center

Asia Cancer Forum

CancerX

Chiba Cancer Center

Foundation for Promotion of Cancer Research

Higashi Sapporo Hospital

Hokkaido Cancer Society

Japan Cancer Society

Japan Federation of Cancer Patient Groups

Japan Lung Cancer Society

Japan Society of Clinical Oncology

Japan Society of Gynecologic Oncology

Japanese Breast Cancer Society

Japanese Cancer Association (JCA)

Japanese Foundation for Cancer Research (JFCR)

Japanese Foundation for Multidisciplinary Cancer Treatment

Jikei University School of Medicine

Kanagawa Cancer Center

Kyushu Cancer Center

Mie University Hospital

Miyagi Cancer Center

National Cancer Center - Japan

Niigata Cancer Center

NPO Maggie’s Tokyo

Osaka International Cancer Institute

Princess Takamatsu Cancer Research Fund

Saitama Cancer Center

Sapporo Cancer Seminar Foundation

Sasaki Foundation

Shizuoka Cancer Center

Tochigi Cancer Center

Tokyo Metropolitan Komagome Hospital

JORDAN

Jordan Cancer Society

King Hussein Cancer Center

King Hussein Cancer Foundation

Ministry of Health-Jordan / Cancer Prevention Department and the Jordan Cancer Registry

KAZAKHSTAN

Kazakhstan Cancer Society (KazCS)

Together Against Cancer Kazakhstan

KENYA

Henzo Kenya

International Cancer Institute

International Institute for Legislative Affairs

Kenya Network of Cancer Organizations

Kenya Society of Haematology and Oncology

KILELE Health Association

National Cancer Institute of Kenya

National Nurses Association of Kenya

Women 4 Cancer Early Detection & Treatment

KOREA, REPUBLIC OF

Korea Blood Disease & Cancer Association

Korean Cancer Association

Korean Society of Medical Oncology (KSMO)

Mediram Korean Medicine Hospital

National Cancer Center - Korea (NCCK)

Zero Club

KOSOVO

Women association for fighting breast cancer in Kosovo RENESANSA

KUWAIT

Fadia Survive & Thrive Association

KYRGYZSTAN

Public Foundation “Ergene”

Public Fund Vmeste Protiv Raka –Together against cancer Kyrgyz Republic

LAO PEOPLE’S DEMOCRATIC REPUBLIC

National Cancer Center Laos

LATVIA

Institute of Microbiology & Virology

Limfomas Pacientu Atbalsta

Organizācija

LEBANON

Barbara Nassar Association For Cancer Patient Support

Children’s Cancer Center of Lebanon (CCCL)

Lebanese Breast Cancer Foundation

Lebanese Cancer Society

Naef K. Basile Cancer Institute

LESOTHO

Action Against Cancer Association

LIBYA

National Cancer Control Program (NCCP) Libya

LITHUANIA

National Cancer Institute - Lithuania

OHLB Kraujas

LUXEMBOURG

Een Häerz fir Kriibskrank Kanner

MADAGASCAR

Fondation Akbaraly

Union Malagasy Contre le Cancer

MALAWI

Coalition of Women Living with HIV and AIDS

Women Coalition Against Cancer in Malawi - WOCACA

MALAYSIA

Breast Cancer Welfare Association

Cancer Research Malaysia

Cancer Survivor Malaysia

KanWork Cancer Society

Malaysian Oncological Society

Max Family Society Malaysia

National Cancer Council (MAKNA)

National Cancer Society of Malaysia

Society for Cancer Advocacy and Awareness Kuching (SCAN)

University of Malaya, Faculty of Medicine

MALDIVES

Cancer Society of Maldives

MALI

Association de Lutte contre le Tabac, l’Alcool et les Stupéfiants

Association de Lutte Contre les Maladies Cancéreuses (ALMAC)

Simasoh-Nani International

MARTINIQUE

Association Martiniquaise pour l’information et l’orientation Familiales

MAURITANIA

Association Mauritanienne de lutte contre le cancer

MAURITANIA

Association pour la Santé Préventive de la Femme

Association pour Mieux Vivre avec le Cancer Gynécologique

Ithar Charity Association for Cancer Patients Care

MAURITIUS

Enn Rev Enn Sourir

Leukaemia Foundation

Link to Life

MEXICO

Asociación Gerardo Alfaro A.C.

Asociación Mexicana contra el Cancer de Mama AC “Fundación Cima”

Asociación Mexicana de Ayuda a Niños con Cáncer, IAP (AMANC)

Asociación Mexicana De Leucemia y Gist A.C.

Asociación Mexicana de Lucha Contra el Cáncer A.C.

Cancer Warriors de México, A.C.

Casa de la Amistad para Niños con Cancer I.A.P

FUCAM, A.C.

Fundación COI, A.C.

Fundación Fomento de Desarrollo

Teresa de Jesús, I.A.P (FUTEJE)

Fundación Grisi, VAPORTI Contra el Cancer de Pancreas

Fundación Mexicana para la Planeación Familiar, A.C.

Fundación Rebecca De Alba, A.C.

Fundación Vuela

Hospital Infantil Teletón de Oncología (HITO)

Instituto Nacional de CancerologíaMéxico

Salvati AC

Sociedad Mexicana de Oncología

MONGOLIA

Mongolian Oncology Nursing Society

National Cancer Center of Mongolia

National Cancer Council of Mongolia

Onom Foundation

MOROCCO

AMAL (Association des Malades

Atteints de Leucémies)

Association de Soutien des Cancéreux de l’Oriental

Association SOS Face Marrakech

Dar Zhor Association

Ensemble contre le Lymphome (ECL)

NABD-BC2 (Best Care for Breast Cancer Association)

MOZAMBIQUE

Beira Cancer Registry

MYANMAR

Pun Yaung Hnin Si (Pink Rose) Breast Cancer Patients Support Group

Shwe Yaung Hnin Si Cancer Foundation

NAMIBIA

Cancer Association of Namibia

NEPAL

B.P. Koirala Memorial Cancer Hospital

Children’s Cancer Foundation

Nepal Cancer Relief Society (NCRS)

Nursing Association of Nepal (NAN)

Tulasi Maya Memorial Cancer Relief Foundation

NETHERLANDS (THE)

Childhood Cancer International (CCI)

Dutch Cancer Society (KWF)

European Waldenström Macroglobulinemia Network (EWMnetwork)

Hematon

IKNL Integraal Kankercentrum Nederland

International Kidney Cancer Coalition (IKCC)

LymfklierkankerVereniging Nederland

Stichting Merels Wereld

Stichting Prinses Máxima Centrum Foundation

Wereld Kanker Onderzoek Fonds (WCRF NL)

NEW ZEALAND

Cancer Society of New Zealand Inc.

Leukaemia & Blood Cancer New Zealand

Te Aho o Te Kahu - Cancer Control Agency

NICARAGUA

Asociación Pro-Bienestar de la Familia

Nicaraguense

Fundación Alas de Vida

Fundación Movimiento Contra el Cáncer (Movicancer-Nicaragua)

Fundacion Ortiz Gurdian

NIGER

Centre National de Lutte contre le Cancer

Ligue Nigérienne de Lutte contre le Cancer (LNLC)

SOS Cancer Niger

SOS Tabagisme

TATALLI

Tous Unis Contre le Cancer

NIGERIA

Access to Basic Medical Care

Foundation

Atinuke Cancer Foundation

Breast Without Spot (BWS) Initiative

Dove-Haven Foundation

End Cervical Cancer Nigeria Initiative

Engraced Life Foundation

Fight4Life Cancer Foundation

First Ladies Against Cancer Initiative

Lami Fatima Babare Cervical Cancer Foundation

Leah Cancer Centre

Lilly Women’s Health

LUTH Advanced Medical Services

Limited

Medicaid Cancer Foundation

Move Against Cancer Africa

National Institute for Cancer Research and Treatment (NICRAT)

Nest of Hope Advocacy and Support Community

Nigerian Cancer Society

Nursing and Midwifery Council of Nigeria

OCI Foundation Ltd

Pink Africa Foundation

Project PINK BLUE - Health & Psychological Trust Centre

Prostate Cancer Transatlantic Consortium, Africa

Raise Foundation Minna

Save a Life Cancer Awareness and Support Network

Society of Oncology and Cancer Research of Nigeria

NORTH MACEDONIA

Association for Support of Patients and Their Caregivers of Hematology Diseases (HEMA)

Borka – for Each New Day

NORWAY

Aktiv mot kreft

Blodkreftforeningen

Norwegian Cancer Society

OMAN

Oman Cancer Association

PAKISTAN

Cancer Patients’ Welfare Society (CPSW) NIMRA

Shaukat Khanum Memorial Cancer

Hospital & Research Centre

Society of Medical Oncology Pakistan

PALESTINE, STATE OF

Aid and Hope Program for Cancer Patient Care

Istishari Arab Hospital

Patient’s Friend’s Society-Jerusalem

PANAMA

Asociación Nacional Contra el Cáncer

Asociación Panameña para el Planeamiento de la Familia

Panamanian Oncology Nursing Society

PAPUA NEW GUINEA

Papua New Guinea Cancer Foundation

Papua New Guinea National Cancer Centre

PARAGUAY

Centro Paraguayo de Estudios de Población

Fundacion Unidos Contra El CancerFUNCA Paraguay

PERU

Albergue Inspira ALIADA

AUNA Oncosalud

Con L de Leucemia

ESPERANTRA

Fundación Peruana de Cáncer

Instituto Peruano de Paternidad Responsable

IPOR Instituto Peruano de Oncología & Radioterapia

Liga Peruana contra el cáncer Luz de Esperanza

Por Un Perú Sin Cáncer

Sociedad Peruana De Enfermeras

Oncólogas

PHILIPPINES

Benavides Cancer Institute, University of Santo Tomas Hospital

Cancer Coalition Philippines

Cancer Warriors Foundation, Inc

Gift2Life Inc

I Can Serve Foundation

Kythe Foundation Inc.

Philippine Alliance of Patient Organizations, Inc. (PAPO)

Philippine Cancer Society

Philippine College of Surgeons

Cancer Commission Foundation (PCS CanCom)

Philippine Oncology Nurses Association Inc.

Philippine Society of Oncologists, Inc.

Touched By Max

POLAND

Fundacja Onkologiczna Rakiety

International Hereditary Cancer Center

Polish Lymphoma Association

The Polish Sarcoma and Melanoma Patients Association

PORTUGAL

AEOP - Portuguese Association Oncology Nurse

Associação Advanced Breast Cancer

Global Alliance

Associacao Portuguesa Contra a Leucemia (APCL)

Assoçiacão Portuguesa de Leucemias e Linfomas (APLL)

Champalimaud Foundation

Liga Portuguesa Contra o Cancro

PUERTO RICO

Asociación Puertorriqueña ProBienestar de la Familia

Liga Puertorriqueña Contra el Cáncer y su Hospital Oncológico Dr. Isaac González Martínez

QATAR

Qatar Cancer Society

The Qatar Scientific Oncology Innovation and Networking Society (Q-SOINS)

ROMANIA

Asociatia Bolnavilor cu LimfoameLymphoma Patients Association of Romania

Asociatia Daruieste Viata / Give Life Association

Asociatia MagiCAMP

Asociatia Med San

Foundation HOSPICE Casa Sperantei

Institutul Oncologic “Prof. Dr. Ion Chiricuta” Cluj-Napoca (IOCN)

Romanian Association against Leukemia

Romanian Nursing Association (RNA)

RUSSIAN FEDERATION

All-Russian National Union “Association of Oncologists of Russia”

Inter-regional Public Organization for Patients with Hematological Diseases Most Miloserdiya (Mercy Bridge)

Society for Assistance to People with Oncohematologic Disease

RWANDA

African Center for Research on End of Life Care (ACREOL)

Butaro Hospital

Rwanda Cancer Relief (RCR)

Rwanda NCD Alliance

Rwanda Palliative Care and Hospice Organisation

University of Global Health Equity (UGHE) Ltd

SAINT KITTS AND NEVIS

Nevis Family Planning Association

St. Kitts Family Life Services Association Ltd.

SAINT LUCIA

St. Lucia Planned Parenthood Association

SAINT VINCENT AND THE GRENADINES

St. Vincent Planned Parenthood Association

SAMOA

Samoa Cancer Society Inc.

SAUDI ARABIA

Cancer Control Charity Association in Al-Hasa (Tafaul)

Ministry of Health - Saudi Arabia

National Cancer Center - Saudi Health Council

Zahra Breast Cancer Association

SENEGAL

Association Cancer du Sein du Sénégal

Ligue Sénégalaise Contre le Cancer (LISCA)

SERBIA

LIPA Lymphoma Patient Association

Oncology Nursing Section, Nurses Association of Serbia

Serbian Society for the Fight Against Cancer

SIERRA LEONE

Crusaders Club Ministry Sierra Leone

MEPS Trust Well Woman Clinic

Thinking Pink Breast Cancer Foundation

SINGAPORE

Asia Pacific Hospice Palliative Care Network

Leukemia & Lymphoma Foundation

National Cancer Center - Singapore

Singapore Cancer Society

SLOVAKIA

Association of Patients with Hematological Malignancies

Lymfoma Slovensko

Slovak League Against Cancer

SLOVENIA

Association of Patients with Blood Diseases Slovenia

Društvo bolnikov z limfomomSlovenian Lymphoma Patients Association

Ljubljana Institute of Oncology

Slovenian Coalition for Public Health, Environment and Tobacco Control

Slovensko Združenje Bolnikov z Limfomom in Levkemijo, L&L -

Slovenian Association of Patients with Lymphoma and Leukemia

SOMALIA

Ministry of Health - Somalia

Somali Cancer Society

SOUTH AFRICA

African Organisation for Research & Training in Cancer (AORTIC)

Campaigning for Cancer

Cancer Association of South Africa

National Cancer Registry, Division of the National Health Laboratory Service, South Africa

National Oncology Nursing Society of South Africa

People Living with Cancer (PLWC)

PinkDrive

Warriors With A Purpose

SPAIN

AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia

Asociación Española Contra el Cáncer

Federación Española de Cancer de Mama

Fundación Aladina

Fundación Sandra Ibarra de

Solidaridad Frente al Cáncer

Institut Catala d’Oncologia

Vall Hebron Institut of Oncology (VHIO)

SRI LANKA

Indira Cancer Trust

Sri Lanka Cancer Society

SURINAME

Stichting Lobi

SWEDEN

Barncancerfonden

Blodcancerförbundet

Swedish Cancer SocietyCancerfonden

SWITZERLAND

Cancer Support Switzerland

CANSEARCH Foundation

COLORECTUM - Patientennetz Darmkrebs

European Organization for Nuclear Research (CERN)

European Society for Medical Oncology (ESMO)

Fondation ISREC

GAVI Vaccine Alliance

Global Coalition for Radiotherapy

HUG - Hôpitaux Universitaires de Genève

International Society of Paediatric Oncology (SIOP)

Léman hope Foundation

Lung Cancer Europe (LuCE)

Lymphome.ch Patientennetz Schweiz pretac+ association pour le dépistage tactile

Sharing Progress in Cancer Care

Swiss Cancer League

TEST Viran

World Hepatitis Alliance

Zoé4life

SYRIAN ARAB REPUBLIC

Amal Association for Cancer

Association Médicale Franco-Syrienne

Syrian Society to Cure Cancer of Children and Care Them

TAIWAN (PROVINCE OF CHINA)

Formosa Cancer Foundation

Health Promotion Administration, Ministry of Health and Welfare Taiwan

Hope Foundation for Cancer Care

Taiwan Cancer Total-Care Information Society

TAJIKISTAN

NGO AVESTO Tajikistan

TANZANIA, UNITED REPUBLIC OF

Aga Khan Health Services, Tanzania (AKHST)

Cancer Care Centre, Kilimanjaro Christian Medical Centre (KCMC)

Ocean Road Cancer Institute

Shujaa Cancer Foundation

Tumaini La Maisha Tanzania

Zanzibar Outreach Program (ZOP)

THAILAND

MaxSmiles

National Cancer Institute - Thailand

Thai Cancer Society by Cancer Network Foundation

Thai International Chemotherapy Society

TIMOR-LESTE

Alola Foundation

TOGO

Association pour la Promotion de la Santé et du Bien-Etre Social (APSBES)

Ligue Togolaise Contre le Cancer

TRINIDAD AND TOBAGO

Family Planning Association of Trinidad and Tobago

TUNISIA

Association des Malades du Cancer

Association SELIMA

Association Tunisienne Contre le Cancer

Association Tunisienne d’Assistance aux Malades du Cancer du Sein

Association Tunisienne de Soins Palliatifs - Gabès

Association Tunisienne des SagesFemmes

Association Tunisienne des Soins Palliatifs

TURKEY

BIRKAN

Fondation des Enfants Atteints de la Leucémie KÖKDER

Ministry of Health - Turkey

Turkish Association for Cancer Research and Control (TACRC)

Turkish Oncology Nursing Society

UGANDA

African Palliative Care Association

Ananda Centre for Cancer Research

Hematology & Oncology Society of Uganda (HOSU) Ltd

Medical and Community Support

Organisation Uganda

Uganda Cancer Institute

Uganda Cancer Society

Uganda Women’s Cancer Support Organization (UWOCASO)

UKRAINE

Charity Foundation Inspiration Family

Global Medical Knowledge Alliance Ukraine

National Cancer Institute, Kiev, Ukraine

Ukrainian Public Association for Patients with Chronic Lymphoproliferative Diseases

UNITED ARAB EMIRATES

Burjeel Medical City - VPS HealthCare LLC

Emirates Oncology Society

Friends of Cancer Patients (FoCP)

Gulf International Cancer Center

UNITED KINGDOM

Cancer Research UK

Johnston Cancer Research Centre

Queen’s University Belfast

King’s Health Partners Comprehensive Cancer Centre

Leukaemia CARE

London Global Cancer Week

Lymphoma Action

Lymphoma Association

Macmillan Cancer Support

Maggie’s Cancer Caring Centres

NHS England

The Christie NHS Foundation Trust

World Cancer Research Fund (WCRF UK)

World Cancer Research Fund International (WCRF)

World Child Cancer

Worldwide Cancer Research

UNITED STATES

Abramson Cancer Center, University of Pennsylvania

Academy of Oncology Nurse & Patient Navigators (AONN+)

ALSAC/St. Jude Children’s Research Hospital

American Association for Cancer Research - AACR

American Cancer Society

American Childhood Cancer Organization

American Institute for Cancer Research

American Society for Clinical Pathology (ASCP)

American Society for Radiation Oncology (ASTRO)

American Society of Clinical Oncology (ASCO)

Basic Health International, Inc

Campaign for Tobacco-Free Kids

CancerCare

Centers for Disease Control and Prevention (CDC)

Cervivor, Inc.

Chicago Blood and Cancer Foundation

CLL Society

College of American Pathologists

Cutaneous Lymphoma Foundation

Dana-Farber Cancer Institute

Direct Relief

ECHO Institute at the University of New Mexico

Fòs Feminista: International Alliance for Sexual and Reproductive Health, Rights, and Justice

Fred Hutchinson Cancer Center

Global Colon Cancer Association

Global Focus on Cancer

Global Initiative Against HPV and Cervical Cancer (GIAHC)

Houston Methodist Neal Cancer Center

Indiana University Simon Cancer Center

International Association for the Study of Lung Cancer (IASLC)

International Gynecologic Cancer Society

International Neuroendocrine Cancer Alliance (INCA)

International Waldenstrom’s Macroglobulinemia Foundation (IWMF)

Jhpiego Corporation

Know Your Lemons Foundation

Legorreta Cancer Center at Brown University

Leukemia & Lymphoma Society

Love Hope Strength Foundation

LUNGevity Foundation

Lymphoma Research Foundation

Mayo Clinic

Memorial Sloan Kettering Cancer Center

Missouri Cancer Registry and Research Center

Moffitt Cancer Center

National Cancer Institute - USA

National Comprehensive Cancer Network (NCCN)

National Foundation for Cancer Research

North American Association of Central Cancer Registries

Oncology Nursing Society PATH

Patients Against Lymphoma (PAL)

Perlmutter Cancer Center, NYU Langone Health

Prevent Cancer Foundation

Reach to Recovery International Rutgers Global Health Institute

Society of Surgical Oncology

St. Baldrick’s Foundation

St. Jude Children’s Research Hospital Stand Up To Cancer

Susan G. Komen

T-Cell Leukemia Lymphoma Foundation

Texas Children’s Hospital - Global HOPE

The Eye Cancer Foundation

The George Washington University Cancer Center

The Max Foundation

The Ohio State University

Comprehensive Cancer Center

The Skin Cancer Foundation

The University of Texas MD Anderson Cancer Center

TogetHER for Health

UCSF Helen Diller Family

Comprehensive Cancer Center

University of Colorado Cancer Center

University of Hawaii Cancer Center

University of Miami - Sylvester Comprehensive Cancer Center

UW Carbone Cancer Center

World Child Cancer USA

Young Survival Coalition

URUGUAY

Asociación Uruguaya de Planificación Familiar (AUPF)

Comisión Honoraria de Lucha contra el Cáncer

Fundación Porsaleu

Grupo Linfoma Uruguay

VANUATU

Ikkana Cancer Society

Vanuatu Family Health Association

VENEZUELA BOLIVARIAN

REPUBLIC OF

Asociación Civil de Planificación Familiar

Asociación de Ayuda a Pacientes Hemato-Oncologicos “ASAPHE”

Asociación Venezolana de Amigos con Linfoma

Fundación Hemato-Oncológica Guyana (Fundahog)

Sociedad Anticancerosa de Venezuela

Venezuelan Breast Cancer Research and Education Foundation

VIET NAM

Hanoi Oncology Hospital

Supportive Fund For Cancer PatientsBright Future

VIRGIN ISLANDS, BRITISH

BVI Family Life Association

VIRGIN ISLANDS, U.S.

Virgin Islands Family Planning Association

YEMEN

National Cancer Control Foundation

Shabwah Cancer Control Foundation

ZAMBIA

Teal Sisters Foundation

Tobacco Free Association of Zambia

Zambian Cancer Society

ZIMBABWE

Cancer Association of ZimbabweHarare Branch

Cancer Care Network Trust Zimbabwe

Cancerserve Trust

Hospice & Palliative Care Association of Zimbabwe

Zimbabwe Brain Tumour Association